| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | SLIT2 HSPG2 FBLN1 FRAS1 FBN2 MATN3 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 SRPX FGG LTBP4 | 4.85e-17 | 188 | 82 | 16 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | SELP SNED1 SLIT2 BMP1 HSPG2 FBLN1 FAT4 STAB2 FBN2 PLCH2 MATN3 GAS6 NID1 DLK1 LTBP2 DLL1 LTBP4 SVEP1 | 1.09e-09 | 749 | 82 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | SLIT2 HSPG2 FBLN1 FRAS1 FBN2 MATN3 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 SRPX FGG LTBP4 | 5.67e-07 | 891 | 82 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | integrin binding | 7.70e-06 | 175 | 82 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.43e-05 | 268 | 82 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity | 1.67e-05 | 2 | 82 | 2 | GO:0030144 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 1.85e-05 | 13 | 82 | 3 | GO:0043208 | |
| GeneOntologyMolecularFunction | growth factor activity | 7.88e-05 | 173 | 82 | 6 | GO:0008083 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 7.99e-05 | 547 | 82 | 10 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 8.88e-05 | 554 | 82 | 10 | GO:0030546 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 2.11e-04 | 616 | 82 | 10 | GO:0030545 | |
| GeneOntologyMolecularFunction | sphingolipid binding | 3.64e-04 | 34 | 82 | 3 | GO:0046625 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 4.59e-04 | 8 | 82 | 2 | GO:0043237 | |
| GeneOntologyMolecularFunction | cytokine activity | 5.74e-04 | 250 | 82 | 6 | GO:0005125 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 7.74e-04 | 599 | 82 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.07e-03 | 49 | 82 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | heparin binding | 1.17e-03 | 192 | 82 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.21e-03 | 51 | 82 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | BMP receptor binding | 1.26e-03 | 13 | 82 | 2 | GO:0070700 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.38e-03 | 73 | 82 | 3 | GO:0050840 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | MYF5 BMP1 HSPG2 FBLN1 SPINT1 PRICKLE1 MATN3 GAS6 LAMA1 LAMA2 LAMB1 NID1 CPB2 LTBP4 | 3.08e-10 | 377 | 83 | 14 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | MYF5 BMP1 HSPG2 FBLN1 SPINT1 PRICKLE1 MATN3 GAS6 LAMA1 LAMA2 LAMB1 NID1 CPB2 LTBP4 | 3.19e-10 | 378 | 83 | 14 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | MYF5 BMP1 HSPG2 FBLN1 SPINT1 PRICKLE1 MATN3 GAS6 LAMA1 LAMA2 LAMB1 NID1 CPB2 LTBP4 | 3.30e-10 | 379 | 83 | 14 | GO:0045229 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SLIT2 MYF5 BMP1 HSPG2 BMP5 BMP7 FAT4 FRAS1 FBN2 PTPRM PRICKLE1 MICAL2 LAMA1 DVL2 LAMA2 LAMA3 LAMA5 LAMB1 NKX2-5 CPB2 DLL1 MEGF11 | 3.54e-09 | 1269 | 83 | 22 | GO:0009887 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 3.68e-08 | 124 | 83 | 8 | GO:0007229 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 7.87e-08 | 11 | 83 | 4 | GO:0110011 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | SNED1 MYF5 FBLN1 GAS6 LAMA5 LAMB1 NID1 FGG ITGAM ZYX CD96 SVEP1 | 8.79e-08 | 410 | 83 | 12 | GO:0031589 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | SLIT2 BMP5 BMP7 FAT4 SPINT1 PRICKLE1 MICAL2 LAMA1 DVL2 LAMA5 NKX2-5 DLL1 | 1.17e-07 | 421 | 83 | 12 | GO:0060562 |
| GeneOntologyBiologicalProcess | skeletal system development | MYF5 BMP1 HSPG2 BMP5 BMP7 FAT4 BMP8B FBN2 MCPH1 MATN3 LAMA5 DLK1 BMP8A GDF10 | 1.51e-07 | 615 | 83 | 14 | GO:0001501 |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 2.37e-07 | 14 | 83 | 4 | GO:2001046 | |
| GeneOntologyBiologicalProcess | embryo development | ACSL4 SLIT2 MYF5 HSPG2 BMP5 BMP7 BMP8B FRAS1 FBN2 SPINT1 PRICKLE1 MICAL2 LAMA1 DVL2 LAMA2 LAMA3 LAMA5 NKX2-5 DLK1 DLL1 | 7.49e-07 | 1437 | 83 | 20 | GO:0009790 |
| GeneOntologyBiologicalProcess | basement membrane organization | 7.97e-07 | 43 | 83 | 5 | GO:0071711 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | MYF5 HSPG2 BMP5 BMP7 BMP8B FRAS1 FBN2 SPINT1 PRICKLE1 MICAL2 DVL2 LAMA5 NKX2-5 DLL1 | 8.91e-07 | 713 | 83 | 14 | GO:0048598 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | SLIT2 BMP5 BMP7 FAT4 FRAS1 SPINT1 PRICKLE1 MICAL2 LAMA1 DVL2 LAMA5 NKX2-5 DLL1 | 1.09e-06 | 619 | 83 | 13 | GO:0002009 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | SLIT2 MYF5 BMP5 BMP7 FAT4 FRAS1 SPINT1 PRICKLE1 MICAL2 LAMA1 DVL2 LAMA5 NKX2-5 DLL1 | 1.62e-06 | 750 | 83 | 14 | GO:0048729 |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 2.04e-06 | 23 | 83 | 4 | GO:2001044 | |
| GeneOntologyBiologicalProcess | axon guidance | 2.18e-06 | 285 | 83 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.24e-06 | 286 | 83 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | ossification | MYF5 BMP1 HSPG2 BMP5 BMP7 FAT4 BMP8B FBN2 PRICKLE1 DLK1 BMP8A GDF10 | 2.48e-06 | 562 | 83 | 12 | GO:0001503 |
| GeneOntologyBiologicalProcess | heart morphogenesis | 5.73e-06 | 321 | 83 | 9 | GO:0003007 | |
| GeneOntologyBiologicalProcess | cartilage development | 6.09e-06 | 243 | 83 | 8 | GO:0051216 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | SLIT2 BMP5 BMP7 FAT4 BMP8B FBN2 SPINT1 GAS6 LTBP2 BMP8A DLL1 GDF10 LTBP4 ZYX | 6.87e-06 | 850 | 83 | 14 | GO:0071363 |
| GeneOntologyBiologicalProcess | pattern specification process | MYF5 BMP1 BMP5 BMP7 PRICKLE1 MICAL2 DVL2 LAMA5 NKX2-5 DLL1 ITGAM | 8.22e-06 | 526 | 83 | 11 | GO:0007389 |
| GeneOntologyBiologicalProcess | tube morphogenesis | SLIT2 HSPG2 BMP5 BMP7 FAT4 STAB2 SPINT1 PTPRM PRICKLE1 MICAL2 CYSLTR1 LAMA1 DVL2 LAMA5 NKX2-5 DLL1 | 8.98e-06 | 1125 | 83 | 16 | GO:0035239 |
| GeneOntologyBiologicalProcess | response to growth factor | SLIT2 BMP5 BMP7 FAT4 BMP8B FBN2 SPINT1 GAS6 LTBP2 BMP8A DLL1 GDF10 LTBP4 ZYX | 1.06e-05 | 883 | 83 | 14 | GO:0070848 |
| GeneOntologyBiologicalProcess | neuron projection development | ACSL4 SLIT2 HSPG2 BMP5 BMP7 FAT4 HECW1 PTPRM PRICKLE1 CNTNAP1 LAMA1 DVL2 LAMA2 LAMA3 LAMA5 LAMB1 PRAG1 | 1.16e-05 | 1285 | 83 | 17 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.31e-05 | 270 | 83 | 8 | GO:0007160 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 1.56e-05 | 199 | 83 | 7 | GO:0051147 | |
| GeneOntologyBiologicalProcess | axonogenesis | SLIT2 HSPG2 BMP7 PTPRM PRICKLE1 CNTNAP1 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 | 1.63e-05 | 566 | 83 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SLIT2 HSPG2 BMP7 HECW1 PTPRM PRICKLE1 CNTNAP1 LAMA1 DVL2 LAMA2 LAMA3 LAMA5 LAMB1 | 1.80e-05 | 802 | 83 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | SELP MYF5 HSPG2 BMP7 FBLN1 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 FGG DLL1 CYTIP | 1.82e-05 | 927 | 83 | 14 | GO:0030155 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SLIT2 HSPG2 BMP7 HECW1 PTPRM PRICKLE1 CNTNAP1 LAMA1 DVL2 LAMA2 LAMA3 LAMA5 LAMB1 | 2.24e-05 | 819 | 83 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 2.25e-05 | 84 | 83 | 5 | GO:1903053 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SLIT2 HSPG2 BMP7 HECW1 PTPRM PRICKLE1 CNTNAP1 LAMA1 DVL2 LAMA2 LAMA3 LAMA5 LAMB1 | 2.45e-05 | 826 | 83 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SLIT2 HSPG2 BMP7 HECW1 PTPRM PRICKLE1 CNTNAP1 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 | 4.33e-05 | 748 | 83 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of cell motility | SELP SLIT2 BMP5 BMP7 FBLN1 MGAT5 FBN2 PTPRM PATZ1 GAS6 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 PRAG1 | 4.38e-05 | 1280 | 83 | 16 | GO:2000145 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | SLIT2 MYF5 BMP7 FBN2 SPINT1 CYSLTR1 GAS6 LAMA1 LAMA2 LAMB1 NKX2-5 NID1 DLK1 ITGAM GDF10 | 4.45e-05 | 1141 | 83 | 15 | GO:0045597 |
| GeneOntologyBiologicalProcess | neural fold elevation formation | 4.79e-05 | 3 | 83 | 2 | GO:0021502 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 4.97e-05 | 99 | 83 | 5 | GO:0045995 | |
| GeneOntologyBiologicalProcess | axon development | SLIT2 HSPG2 BMP7 PTPRM PRICKLE1 CNTNAP1 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 | 5.15e-05 | 642 | 83 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuron development | ACSL4 SLIT2 HSPG2 BMP5 BMP7 FAT4 HECW1 PTPRM PRICKLE1 CNTNAP1 LAMA1 DVL2 LAMA2 LAMA3 LAMA5 LAMB1 PRAG1 | 6.09e-05 | 1463 | 83 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of locomotion | SELP SLIT2 BMP5 BMP7 FBLN1 MGAT5 FBN2 PTPRM PATZ1 GAS6 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 PRAG1 | 6.74e-05 | 1327 | 83 | 16 | GO:0040012 |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 6.88e-05 | 106 | 83 | 5 | GO:0051149 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | BMP5 BMP7 FAT4 BMP8B FBN2 PRICKLE1 ZNF592 GAS6 LTBP2 BMP8A DLL1 GDF10 LTBP4 ZYX SVEP1 | 6.90e-05 | 1186 | 83 | 15 | GO:0007167 |
| GeneOntologyBiologicalProcess | connective tissue development | 7.19e-05 | 343 | 83 | 8 | GO:0061448 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SLIT2 HSPG2 BMP7 HECW1 PTPRM PRICKLE1 CNTNAP1 LAMA1 DVL2 LAMA2 LAMA3 LAMA5 LAMB1 PRAG1 ZMYM6 | 7.45e-05 | 1194 | 83 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 7.48e-05 | 445 | 83 | 9 | GO:0141091 | |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 8.19e-05 | 57 | 83 | 4 | GO:0061383 | |
| GeneOntologyBiologicalProcess | embryonic organ development | MYF5 HSPG2 BMP5 BMP7 SPINT1 PRICKLE1 MICAL2 DVL2 NKX2-5 DLL1 | 8.37e-05 | 561 | 83 | 10 | GO:0048568 |
| GeneOntologyBiologicalProcess | regulation of cell migration | SELP SLIT2 BMP5 BMP7 FBLN1 MGAT5 FBN2 PTPRM PATZ1 GAS6 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 | 8.73e-05 | 1211 | 83 | 15 | GO:0030334 |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 9.37e-05 | 59 | 83 | 4 | GO:0085029 | |
| GeneOntologyBiologicalProcess | allantois development | 9.55e-05 | 4 | 83 | 2 | GO:1905069 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 1.18e-04 | 190 | 83 | 6 | GO:0016331 | |
| GeneOntologyBiologicalProcess | primary neural tube formation | 1.24e-04 | 120 | 83 | 5 | GO:0014020 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.24e-04 | 276 | 83 | 7 | GO:0007179 | |
| GeneOntologyBiologicalProcess | tube development | SLIT2 HSPG2 BMP5 BMP7 FAT4 STAB2 SPINT1 PTPRM PRICKLE1 MICAL2 CYSLTR1 LAMA1 DVL2 LAMA5 NKX2-5 DLL1 | 1.28e-04 | 1402 | 83 | 16 | GO:0035295 |
| GeneOntologyBiologicalProcess | regionalization | 1.29e-04 | 478 | 83 | 9 | GO:0003002 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.37e-04 | 482 | 83 | 9 | GO:0007178 | |
| GeneOntologyBiologicalProcess | regulation of cardioblast differentiation | 1.59e-04 | 5 | 83 | 2 | GO:0051890 | |
| GeneOntologyBiologicalProcess | sensory organ development | MYF5 BMP5 BMP7 FAT4 PTPRM PRICKLE1 LAMA1 DVL2 NKX2-5 DLL1 MEGF11 | 1.61e-04 | 730 | 83 | 11 | GO:0007423 |
| GeneOntologyBiologicalProcess | renal system development | 1.62e-04 | 386 | 83 | 8 | GO:0072001 | |
| GeneOntologyBiologicalProcess | circulatory system development | SLIT2 HSPG2 BMP5 BMP7 FAT4 STAB2 SPINT1 PTPRM PRICKLE1 MICAL2 CYSLTR1 LAMA1 DVL2 NKX2-5 DLL1 SVEP1 | 1.78e-04 | 1442 | 83 | 16 | GO:0072359 |
| GeneOntologyBiologicalProcess | labyrinthine layer morphogenesis | 1.91e-04 | 28 | 83 | 3 | GO:0060713 | |
| GeneOntologyBiologicalProcess | branching involved in salivary gland morphogenesis | 1.91e-04 | 28 | 83 | 3 | GO:0060445 | |
| GeneOntologyBiologicalProcess | neural tube formation | 2.08e-04 | 134 | 83 | 5 | GO:0001841 | |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 2.15e-04 | 73 | 83 | 4 | GO:0001738 | |
| GeneOntologyBiologicalProcess | heart looping | 2.15e-04 | 73 | 83 | 4 | GO:0001947 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 2.26e-04 | 74 | 83 | 4 | GO:0002011 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | SLIT2 MYF5 HSPG2 BMP5 BMP7 STAB2 FBN2 SPINT1 PTPRM PRICKLE1 CYSLTR1 CNTNAP1 DVL2 NKX2-5 DLL1 MEGF11 | 2.44e-04 | 1483 | 83 | 16 | GO:0048646 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 2.81e-04 | 531 | 83 | 9 | GO:0042692 | |
| GeneOntologyBiologicalProcess | determination of heart left/right asymmetry | 2.91e-04 | 79 | 83 | 4 | GO:0061371 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 3.06e-04 | 80 | 83 | 4 | GO:0003143 | |
| GeneOntologyBiologicalProcess | embryonic placenta morphogenesis | 3.14e-04 | 33 | 83 | 3 | GO:0060669 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | ACSL4 SLIT2 MYF5 HSPG2 BMP5 BMP7 SPINT1 PRICKLE1 DVL2 NKX2-5 DLK1 DLL1 | 3.30e-04 | 929 | 83 | 12 | GO:0009792 |
| GeneOntologyBiologicalProcess | pharyngeal system development | 3.44e-04 | 34 | 83 | 3 | GO:0060037 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SELP SLIT2 BMP5 BMP7 FAT4 PTPRM PRICKLE1 LAMA3 LAMB1 FGG ITGAM MEGF11 SVEP1 | 3.51e-04 | 1077 | 83 | 13 | GO:0098609 |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 3.81e-04 | 236 | 83 | 6 | GO:0061138 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 4.11e-04 | 336 | 83 | 7 | GO:0071560 | |
| GeneOntologyBiologicalProcess | regulation of cardiocyte differentiation | 4.42e-04 | 37 | 83 | 3 | GO:1905207 | |
| GeneOntologyBiologicalProcess | embryonic epithelial tube formation | 4.57e-04 | 159 | 83 | 5 | GO:0001838 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 4.59e-04 | 89 | 83 | 4 | GO:0060411 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 4.65e-04 | 343 | 83 | 7 | GO:0071559 | |
| GeneOntologyBiologicalProcess | heart trabecula morphogenesis | 4.79e-04 | 38 | 83 | 3 | GO:0061384 | |
| GeneOntologyBiologicalProcess | salivary gland morphogenesis | 4.79e-04 | 38 | 83 | 3 | GO:0007435 | |
| GeneOntologyBiologicalProcess | vasculature development | SLIT2 HSPG2 BMP7 STAB2 SPINT1 PTPRM PRICKLE1 CYSLTR1 LAMA1 NKX2-5 DLL1 SVEP1 | 4.82e-04 | 969 | 83 | 12 | GO:0001944 |
| GeneOntologyBiologicalProcess | kidney epithelium development | 4.98e-04 | 162 | 83 | 5 | GO:0072073 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 5.34e-04 | 351 | 83 | 7 | GO:0048562 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 5.65e-04 | 94 | 83 | 4 | GO:0003151 | |
| GeneOntologyBiologicalProcess | neural fold formation | 5.65e-04 | 9 | 83 | 2 | GO:0001842 | |
| GeneOntologyBiologicalProcess | pericardium morphogenesis | 5.65e-04 | 9 | 83 | 2 | GO:0003344 | |
| GeneOntologyBiologicalProcess | metanephros development | 5.88e-04 | 95 | 83 | 4 | GO:0001656 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 6.10e-04 | 258 | 83 | 6 | GO:0001763 | |
| GeneOntologyBiologicalProcess | blood coagulation | 6.35e-04 | 260 | 83 | 6 | GO:0007596 | |
| GeneOntologyBiologicalProcess | embryo implantation | 6.36e-04 | 97 | 83 | 4 | GO:0007566 | |
| GeneOntologyBiologicalProcess | epithelial tube formation | 6.71e-04 | 173 | 83 | 5 | GO:0072175 | |
| GeneOntologyBiologicalProcess | nephron development | 6.89e-04 | 174 | 83 | 5 | GO:0072006 | |
| GeneOntologyBiologicalProcess | salivary gland development | 6.90e-04 | 43 | 83 | 3 | GO:0007431 | |
| GeneOntologyBiologicalProcess | chorio-allantoic fusion | 7.05e-04 | 10 | 83 | 2 | GO:0060710 | |
| GeneOntologyBiologicalProcess | coagulation | 7.16e-04 | 266 | 83 | 6 | GO:0050817 | |
| GeneOntologyBiologicalProcess | visual system development | 7.24e-04 | 483 | 83 | 8 | GO:0150063 | |
| GeneOntologyCellularComponent | extracellular matrix | SNED1 SLIT2 BMP1 HSPG2 BMP7 FBLN1 FRAS1 FCGBP FBN2 MATN3 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 SRPX FGG GDF10 LTBP4 ITIH2 SVEP1 | 7.60e-16 | 656 | 84 | 23 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | SNED1 SLIT2 BMP1 HSPG2 BMP7 FBLN1 FRAS1 FCGBP FBN2 MATN3 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 SRPX FGG GDF10 LTBP4 ITIH2 SVEP1 | 8.12e-16 | 658 | 84 | 23 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | SLIT2 BMP1 HSPG2 BMP7 FBLN1 FRAS1 FBN2 MATN3 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 SRPX FGG GDF10 LTBP4 ITIH2 | 2.01e-14 | 530 | 84 | 20 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 1.49e-09 | 122 | 84 | 9 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 5.00e-08 | 10 | 84 | 4 | GO:0043256 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 5.55e-07 | 17 | 84 | 4 | GO:0098637 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.92e-06 | 59 | 84 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | laminin-10 complex | 4.77e-05 | 3 | 84 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | laminin-1 complex | 4.77e-05 | 3 | 84 | 2 | GO:0005606 | |
| GeneOntologyCellularComponent | laminin-3 complex | 4.77e-05 | 3 | 84 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | laminin-5 complex | 9.52e-05 | 4 | 84 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | platelet alpha granule | 5.40e-04 | 93 | 84 | 4 | GO:0031091 | |
| GeneOntologyCellularComponent | microfibril | 1.21e-03 | 13 | 84 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | adherens junction | 1.65e-03 | 212 | 84 | 5 | GO:0005912 | |
| GeneOntologyCellularComponent | platelet alpha granule membrane | 2.09e-03 | 17 | 84 | 2 | GO:0031092 | |
| MousePheno | abnormal basement membrane morphology | 4.64e-08 | 40 | 71 | 6 | MP:0004272 | |
| MousePheno | abnormal tail morphology | BMP5 BMP7 FAT4 FRAS1 FBN2 PRICKLE1 SETD5 DVL2 LAMA5 LAMB1 DLL1 SVEP1 | 7.70e-07 | 403 | 71 | 12 | MP:0002111 |
| MousePheno | abnormal heart and great artery attachment | 8.93e-07 | 205 | 71 | 9 | MP:0010426 | |
| MousePheno | abnormal heart and great vessel attachment | 1.01e-06 | 208 | 71 | 9 | MP:0010425 | |
| MousePheno | abnormal aorta morphology | 1.94e-06 | 225 | 71 | 9 | MP:0000272 | |
| MousePheno | abnormal pectoral girdle bone morphology | 2.67e-06 | 301 | 71 | 10 | MP:0004508 | |
| MousePheno | abnormal thoracic cage morphology | MYF5 HSPG2 BMP5 BMP7 FAT4 FRAS1 FBN2 PRICKLE1 SETD5 DVL2 DLK1 LTBP4 | 3.28e-06 | 463 | 71 | 12 | MP:0004624 |
| MousePheno | abnormal cardiac outflow tract development | 5.07e-06 | 134 | 71 | 7 | MP:0006126 | |
| MousePheno | abnormal sternum morphology | 5.39e-06 | 255 | 71 | 9 | MP:0000157 | |
| MousePheno | abnormal rib morphology | 5.75e-06 | 257 | 71 | 9 | MP:0000150 | |
| MousePheno | perimembraneous ventricular septal defect | 7.00e-06 | 92 | 71 | 6 | MP:0010418 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 7.45e-06 | 93 | 71 | 6 | MP:0008823 | |
| MousePheno | abnormal nephron morphology | BMP7 FBLN1 FAT4 FRAS1 MGAT5 PRICKLE1 GAS6 LAMA5 CPB2 MGAT5B DNASE1 | 9.13e-06 | 426 | 71 | 11 | MP:0003881 |
| MousePheno | abnormal ureteric bud morphology | 9.99e-06 | 57 | 71 | 5 | MP:0006032 | |
| MousePheno | double outlet right ventricle | 1.07e-05 | 150 | 71 | 7 | MP:0000284 | |
| MousePheno | abnormal extracellular matrix morphology | 1.13e-05 | 100 | 71 | 6 | MP:0013258 | |
| MousePheno | abnormal urinary system development | 2.06e-05 | 111 | 71 | 6 | MP:0003942 | |
| MousePheno | abnormal systemic artery morphology | 2.21e-05 | 304 | 71 | 9 | MP:0011655 | |
| MousePheno | abnormal heart septum morphology | SLIT2 FBLN1 FAT4 FRAS1 PRICKLE1 SETD5 DVL2 LAMA5 NKX2-5 LTBP4 | 2.47e-05 | 388 | 71 | 10 | MP:0006113 |
| MousePheno | abnormal vertebral column morphology | MYF5 HSPG2 BMP5 BMP7 FBLN1 FAT4 FRAS1 FBN2 PRICKLE1 SETD5 CNTNAP1 DVL2 LAMA2 DLL1 | 3.43e-05 | 787 | 71 | 14 | MP:0004703 |
| MousePheno | ventricular septal defect | 5.11e-05 | 261 | 71 | 8 | MP:0010402 | |
| MousePheno | abnormal interventricular septum morphology | 5.54e-05 | 342 | 71 | 9 | MP:0000281 | |
| MousePheno | abnormal artery morphology | 7.13e-05 | 440 | 71 | 10 | MP:0002191 | |
| MousePheno | epididymis epithelium degeneration | 7.61e-05 | 3 | 71 | 2 | MP:0004934 | |
| MousePheno | abnormal axial skeleton morphology | MYF5 BMP1 HSPG2 BMP5 BMP7 FBLN1 FAT4 FRAS1 FBN2 PRICKLE1 SETD5 CNTNAP1 DVL2 LAMA2 LAMA3 LAMA5 DLK1 DLL1 LTBP4 | 8.47e-05 | 1458 | 71 | 19 | MP:0002114 |
| MousePheno | abnormal vertebrae morphology | MYF5 HSPG2 BMP5 BMP7 FAT4 FRAS1 FBN2 PRICKLE1 SETD5 DVL2 DLL1 | 8.90e-05 | 546 | 71 | 11 | MP:0000137 |
| MousePheno | transposition of great arteries | 9.24e-05 | 47 | 71 | 4 | MP:0004110 | |
| MousePheno | abnormal thyroid cartilage morphology | 9.70e-05 | 18 | 71 | 3 | MP:0002260 | |
| MousePheno | abnormal kidney development | 1.08e-04 | 93 | 71 | 5 | MP:0000527 | |
| MousePheno | abnormal capillary morphology | 1.08e-04 | 93 | 71 | 5 | MP:0003658 | |
| MousePheno | abnormal renal corpuscle morphology | 1.15e-04 | 293 | 71 | 8 | MP:0002827 | |
| MousePheno | abnormal kidney morphology | SLIT2 BMP5 BMP7 FBLN1 FAT4 FRAS1 MGAT5 FBN2 PRICKLE1 SETD5 MICAL2 CYSLTR1 GAS6 LAMA5 CPB2 GDF10 MGAT5B DNASE1 | 1.16e-04 | 1363 | 71 | 18 | MP:0002135 |
| MousePheno | abnormal cyst | 1.17e-04 | 294 | 71 | 8 | MP:0031310 | |
| MousePheno | abnormal joint morphology | 1.72e-04 | 397 | 71 | 9 | MP:0002932 | |
| MousePheno | abnormal viscerocranium morphology | BMP1 HSPG2 BMP5 BMP7 FBLN1 FRAS1 FBN2 PRICKLE1 SETD5 LAMA3 LAMA5 | 1.84e-04 | 593 | 71 | 11 | MP:0005274 |
| MousePheno | abnormal renal glomerular capsule morphology | 2.08e-04 | 107 | 71 | 5 | MP:0002828 | |
| MousePheno | abnormal interatrial septum morphology | 2.08e-04 | 107 | 71 | 5 | MP:0000282 | |
| MousePheno | perinatal lethality, incomplete penetrance | 2.14e-04 | 503 | 71 | 10 | MP:0011090 | |
| MousePheno | abnormal kidney cortex morphology | 2.28e-04 | 324 | 71 | 8 | MP:0000521 | |
| MousePheno | abnormal inflammatory response | SELP HSPG2 BMP5 USP13 BMP8B MGAT5 CYSLTR1 MATN3 LAMA2 LAMA3 CPB2 BMP8A ITGAM LTBP4 MGAT5B DNASE1 CD96 | 2.32e-04 | 1310 | 71 | 17 | MP:0001845 |
| MousePheno | abnormal node of Ranvier morphology | 2.52e-04 | 5 | 71 | 2 | MP:0010732 | |
| MousePheno | abnormal interdigital cell death | 2.52e-04 | 5 | 71 | 2 | MP:0009874 | |
| MousePheno | kidney cyst | 2.74e-04 | 177 | 71 | 6 | MP:0003675 | |
| MousePheno | hydroureter | 3.00e-04 | 26 | 71 | 3 | MP:0000536 | |
| MousePheno | abnormal blood vessel morphology | SELP SLIT2 HSPG2 BMP5 FBLN1 FRAS1 MCPH1 SPINT1 SETD5 PATZ1 LAMA1 ELAPOR1 LAMA5 NKX2-5 NID1 DLK1 DLL1 LTBP4 | 3.05e-04 | 1472 | 71 | 18 | MP:0001614 |
| MousePheno | abnormal jaw morphology | 3.25e-04 | 530 | 71 | 10 | MP:0000454 | |
| MousePheno | decreased metastatic potential | 3.36e-04 | 27 | 71 | 3 | MP:0001273 | |
| MousePheno | abnormal intervertebral disk morphology | 3.68e-04 | 67 | 71 | 4 | MP:0004173 | |
| MousePheno | abnormal renal glomerulus morphology | 3.75e-04 | 264 | 71 | 7 | MP:0005325 | |
| MousePheno | wavy tail | 3.77e-04 | 6 | 71 | 2 | MP:0013179 | |
| MousePheno | abnormal paranode morphology | 3.77e-04 | 6 | 71 | 2 | MP:0010734 | |
| MousePheno | small thyroid cartilage | 3.77e-04 | 6 | 71 | 2 | MP:0030867 | |
| MousePheno | micrognathia | 3.89e-04 | 68 | 71 | 4 | MP:0002639 | |
| MousePheno | abnormal nasal bone morphology | 4.12e-04 | 69 | 71 | 4 | MP:0000102 | |
| MousePheno | abnormal laryngeal cartilage morphology | 4.17e-04 | 29 | 71 | 3 | MP:0002256 | |
| MousePheno | abnormal symphysis morphology | 4.59e-04 | 71 | 71 | 4 | MP:0030877 | |
| MousePheno | limbs/digits/tail phenotype | ACSL4 HSPG2 BMP5 BMP7 FAT4 FRAS1 FBN2 PRICKLE1 SETD5 MATN3 ELAPOR1 DVL2 LAMA5 LAMB1 DLL1 SVEP1 | 4.62e-04 | 1258 | 71 | 16 | MP:0005371 |
| MousePheno | abnormal appendicular skeleton morphology | ACSL4 MYF5 HSPG2 BMP5 BMP7 FAT4 FRAS1 FBN2 PRICKLE1 MATN3 ELAPOR1 DVL2 LTBP4 | 5.09e-04 | 896 | 71 | 13 | MP:0009250 |
| MousePheno | rib bifurcation | 5.10e-04 | 31 | 71 | 3 | MP:0000153 | |
| MousePheno | abnormal kidney vasculature morphology | 5.11e-04 | 73 | 71 | 4 | MP:0000530 | |
| MousePheno | epididymis degeneration | 5.25e-04 | 7 | 71 | 2 | MP:0004935 | |
| MousePheno | hearing/vestibular/ear phenotype | HSPG2 BMP5 BMP7 FBLN1 FAT4 FBN2 MCPH1 PRICKLE1 SETD5 LAMA2 LAMA5 LHFPL2 DNASE1 | 5.60e-04 | 905 | 71 | 13 | MP:0005377 |
| MousePheno | abnormal thoracic aorta morphology | 5.89e-04 | 134 | 71 | 5 | MP:0010468 | |
| MousePheno | abnormal ear morphology | 5.95e-04 | 470 | 71 | 9 | MP:0002102 | |
| MousePheno | muscular ventricular septal defect | 6.25e-04 | 77 | 71 | 4 | MP:0010420 | |
| MousePheno | abnormal interventricular septum muscular part morphology | 6.89e-04 | 79 | 71 | 4 | MP:0010498 | |
| MousePheno | centrally nucleated skeletal muscle fibers | 7.22e-04 | 80 | 71 | 4 | MP:0009404 | |
| MousePheno | abnormal cranium morphology | BMP1 HSPG2 BMP5 BMP7 FBLN1 FRAS1 FBN2 PRICKLE1 SETD5 LAMA2 LAMA3 LAMA5 | 7.39e-04 | 813 | 71 | 12 | MP:0000438 |
| MousePheno | granulomatous inflammation | 7.95e-04 | 36 | 71 | 3 | MP:0002500 | |
| MousePheno | abnormal maxilla morphology | 8.16e-04 | 144 | 71 | 5 | MP:0000455 | |
| MousePheno | abnormal craniofacial bone morphology | BMP1 HSPG2 BMP5 BMP7 FBLN1 FRAS1 FBN2 PRICKLE1 SETD5 LAMA2 LAMA3 LAMA5 | 8.59e-04 | 827 | 71 | 12 | MP:0002116 |
| MousePheno | short nasal bone | 8.62e-04 | 37 | 71 | 3 | MP:0004471 | |
| MousePheno | abnormal truncus arteriosus septation | 8.68e-04 | 84 | 71 | 4 | MP:0010454 | |
| MousePheno | decreased kidney cell proliferation | 8.95e-04 | 9 | 71 | 2 | MP:0011441 | |
| MousePheno | abnormal thrombolysis | 8.95e-04 | 9 | 71 | 2 | MP:0003422 | |
| MousePheno | abnormal cartilaginous joint morphology | 9.07e-04 | 85 | 71 | 4 | MP:0030875 | |
| MousePheno | abnormal presacral vertebrae morphology | 9.74e-04 | 225 | 71 | 6 | MP:0000459 | |
| MousePheno | abnormal renal tubule morphology | 1.02e-03 | 227 | 71 | 6 | MP:0002703 | |
| MousePheno | abnormal apoptosis | FBLN1 FAT4 BMP8B FRAS1 FBN2 MCPH1 SPINT1 PRICKLE1 SETD5 MATN3 LAMA1 LAMA5 BMP8A ITGAM PRAMEF26 DNASE1 | 1.02e-03 | 1353 | 71 | 16 | MP:0001648 |
| MousePheno | atrial septal defect | 1.03e-03 | 88 | 71 | 4 | MP:0010403 | |
| MousePheno | increased embryonic tissue cell apoptosis | 1.07e-03 | 153 | 71 | 5 | MP:0013504 | |
| MousePheno | abnormal programmed cell death | FBLN1 FAT4 BMP8B FRAS1 FBN2 MCPH1 SPINT1 PRICKLE1 SETD5 MATN3 LAMA1 LAMA5 BMP8A ITGAM PRAMEF26 DNASE1 | 1.08e-03 | 1360 | 71 | 16 | MP:0014355 |
| MousePheno | abnormal larynx morphology | 1.08e-03 | 40 | 71 | 3 | MP:0002249 | |
| MousePheno | abnormal ureter morphology | 1.12e-03 | 90 | 71 | 4 | MP:0000534 | |
| MousePheno | short tail | 1.12e-03 | 90 | 71 | 4 | MP:0000592 | |
| MousePheno | heterotaxia | 1.12e-03 | 90 | 71 | 4 | MP:0004133 | |
| MousePheno | impaired branching involved in ureteric bud morphogenesis | 1.17e-03 | 41 | 71 | 3 | MP:0004936 | |
| MousePheno | abnormal skeleton physiology | 1.27e-03 | 632 | 71 | 10 | MP:0001533 | |
| MousePheno | abnormal embryonic tissue morphology | MYF5 BMP1 BMP5 BMP7 FBLN1 FAT4 PRICKLE1 SETD5 PATZ1 DVL2 LAMA5 LHFPL2 NKX2-5 DLL1 | 1.27e-03 | 1116 | 71 | 14 | MP:0002085 |
| MousePheno | increased variability of skeletal muscle fiber size | 1.34e-03 | 43 | 71 | 3 | MP:0009403 | |
| MousePheno | impaired basement membrane formation | 1.36e-03 | 11 | 71 | 2 | MP:0003044 | |
| MousePheno | absent neurocranium | 1.36e-03 | 11 | 71 | 2 | MP:0000075 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | SLIT2 BMP1 HSPG2 BMP7 FBLN1 FRAS1 MCPH1 PATZ1 DVL2 LAMA2 NKX2-5 DLK1 FGG LTBP4 | 1.36e-03 | 1124 | 71 | 14 | MP:0011112 |
| MousePheno | increased apoptosis | FBLN1 FAT4 BMP8B FRAS1 MCPH1 SPINT1 PRICKLE1 SETD5 MATN3 LAMA1 LAMA5 BMP8A PRAMEF26 | 1.52e-03 | 1008 | 71 | 13 | MP:0006042 |
| MousePheno | abnormal branching involved in ureteric bud morphogenesis | 1.53e-03 | 45 | 71 | 3 | MP:0010981 | |
| MousePheno | abnormal xiphoid process morphology | 1.53e-03 | 45 | 71 | 3 | MP:0000159 | |
| MousePheno | abnormal placental labyrinth vasculature morphology | 1.60e-03 | 99 | 71 | 4 | MP:0008803 | |
| MousePheno | skin hemorrhage | 1.62e-03 | 12 | 71 | 2 | MP:0011514 | |
| MousePheno | ostium secundum atrial septal defect | 1.62e-03 | 12 | 71 | 2 | MP:0010405 | |
| MousePheno | small nasal bone | 1.63e-03 | 46 | 71 | 3 | MP:0004470 | |
| Domain | EGF | TMEFF1 SELP SNED1 SLIT2 BMP1 CNTNAP3B HSPG2 FBLN1 FAT4 FRAS1 STAB2 FCGBP FBN2 MATN3 CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA2 LAMA3 LAMA5 LAMB1 NID1 DLK1 LTBP2 DLL1 LTBP4 MEGF11 SVEP1 | 1.43e-34 | 235 | 83 | 29 | SM00181 |
| Domain | EGF-like_dom | TMEFF1 SELP SNED1 SLIT2 BMP1 CNTNAP3B HSPG2 FBLN1 FAT4 FRAS1 STAB2 FCGBP FBN2 MATN3 CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA2 LAMA3 LAMA5 LAMB1 NID1 DLK1 LTBP2 DLL1 LTBP4 MEGF11 SVEP1 | 8.16e-34 | 249 | 83 | 29 | IPR000742 |
| Domain | EGF_2 | TMEFF1 SELP SNED1 SLIT2 BMP1 CNTNAP3B HSPG2 FBLN1 FAT4 STAB2 FBN2 MATN3 CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA2 LAMA3 LAMA5 LAMB1 NID1 DLK1 LTBP2 DLL1 LTBP4 MEGF11 SVEP1 | 8.33e-30 | 265 | 83 | 27 | PS01186 |
| Domain | EGF_1 | TMEFF1 SELP SNED1 SLIT2 BMP1 CNTNAP3B HSPG2 FBLN1 FAT4 STAB2 FBN2 CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA2 LAMA3 LAMA5 LAMB1 NID1 DLK1 LTBP2 DLL1 LTBP4 MEGF11 SVEP1 | 1.09e-28 | 255 | 83 | 26 | PS00022 |
| Domain | EGF-like_CS | TMEFF1 SELP SNED1 SLIT2 BMP1 HSPG2 FBLN1 FAT4 STAB2 FBN2 MATN3 CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA2 LAMA3 LAMA5 LAMB1 NID1 DLK1 LTBP2 DLL1 LTBP4 MEGF11 SVEP1 | 2.03e-28 | 261 | 83 | 26 | IPR013032 |
| Domain | EGF_3 | TMEFF1 SELP SNED1 SLIT2 BMP1 CNTNAP3B HSPG2 FBLN1 FAT4 STAB2 FBN2 MATN3 CNTNAP1 GAS6 CNTNAP3 NID1 DLK1 LTBP2 DLL1 LTBP4 MEGF11 SVEP1 | 2.03e-23 | 235 | 83 | 22 | PS50026 |
| Domain | Growth_fac_rcpt_ | BMP1 HSPG2 FBLN1 FAT4 FRAS1 STAB2 FBN2 MATN3 GAS6 LAMA1 ELAPOR1 LAMA3 LAMA5 LAMB1 NID1 LTBP2 DLL1 LTBP4 SVEP1 | 1.72e-22 | 156 | 83 | 19 | IPR009030 |
| Domain | EGF_CA | SNED1 SLIT2 BMP1 HSPG2 FBLN1 FAT4 STAB2 FBN2 MATN3 GAS6 NID1 DLK1 LTBP2 DLL1 LTBP4 SVEP1 | 1.43e-19 | 122 | 83 | 16 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | SNED1 SLIT2 BMP1 HSPG2 FBLN1 FAT4 STAB2 FBN2 MATN3 GAS6 NID1 DLK1 LTBP2 DLL1 LTBP4 SVEP1 | 1.87e-19 | 124 | 83 | 16 | IPR001881 |
| Domain | LAM_G_DOMAIN | SLIT2 CNTNAP3B HSPG2 FAT4 CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA2 LAMA3 LAMA5 | 7.33e-18 | 38 | 83 | 11 | PS50025 |
| Domain | EGF | SELP SNED1 SLIT2 BMP1 HSPG2 STAB2 MATN3 CNTNAP1 GAS6 CNTNAP3 NID1 DLK1 LTBP2 DLL1 SVEP1 | 9.59e-18 | 126 | 83 | 15 | PF00008 |
| Domain | Laminin_G_2 | SLIT2 CNTNAP3B HSPG2 FAT4 CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA2 LAMA3 LAMA5 | 1.40e-17 | 40 | 83 | 11 | PF02210 |
| Domain | LamG | SLIT2 CNTNAP3B HSPG2 FAT4 CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA2 LAMA3 LAMA5 | 4.57e-17 | 44 | 83 | 11 | SM00282 |
| Domain | ASX_HYDROXYL | SNED1 SLIT2 BMP1 FBLN1 FAT4 FBN2 GAS6 NID1 DLK1 LTBP2 DLL1 LTBP4 SVEP1 | 5.16e-16 | 100 | 83 | 13 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | SNED1 SLIT2 BMP1 FBLN1 FAT4 FBN2 GAS6 NID1 DLK1 LTBP2 DLL1 LTBP4 SVEP1 | 1.13e-15 | 106 | 83 | 13 | IPR000152 |
| Domain | Laminin_G | SLIT2 CNTNAP3B HSPG2 FAT4 CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA2 LAMA3 LAMA5 | 1.29e-15 | 58 | 83 | 11 | IPR001791 |
| Domain | EGF_Ca-bd_CS | SNED1 SLIT2 BMP1 FBLN1 FAT4 FBN2 GAS6 NID1 LTBP2 DLL1 LTBP4 SVEP1 | 1.37e-14 | 97 | 83 | 12 | IPR018097 |
| Domain | EGF_CA | SNED1 SLIT2 BMP1 FBLN1 FAT4 FBN2 GAS6 NID1 LTBP2 DLL1 LTBP4 SVEP1 | 1.76e-14 | 99 | 83 | 12 | PS01187 |
| Domain | hEGF | 3.11e-13 | 28 | 83 | 8 | PF12661 | |
| Domain | - | SLIT2 HSPG2 FAT4 CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA2 LAMA3 LAMA5 SVEP1 | 3.88e-13 | 95 | 83 | 11 | 2.60.120.200 |
| Domain | ConA-like_dom | SLIT2 CNTNAP3B HSPG2 FAT4 PTPRM CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA2 LAMA3 LAMA5 MAMDC4 SVEP1 | 7.93e-13 | 219 | 83 | 14 | IPR013320 |
| Domain | EGF_Lam | 2.30e-12 | 35 | 83 | 8 | SM00180 | |
| Domain | EGF_CA | 4.63e-12 | 86 | 83 | 10 | PF07645 | |
| Domain | Laminin_EGF | 4.73e-12 | 38 | 83 | 8 | IPR002049 | |
| Domain | EGF_LAM_2 | 4.96e-11 | 30 | 83 | 7 | PS50027 | |
| Domain | EGF_LAM_1 | 4.96e-11 | 30 | 83 | 7 | PS01248 | |
| Domain | LAMININ_IVA | 8.50e-11 | 8 | 83 | 5 | PS51115 | |
| Domain | Laminin_B | 8.50e-11 | 8 | 83 | 5 | PF00052 | |
| Domain | LamB | 8.50e-11 | 8 | 83 | 5 | SM00281 | |
| Domain | Laminin_IV | 8.50e-11 | 8 | 83 | 5 | IPR000034 | |
| Domain | Laminin_EGF | 1.61e-10 | 35 | 83 | 7 | PF00053 | |
| Domain | Laminin_G_1 | 6.94e-10 | 11 | 83 | 5 | PF00054 | |
| Domain | Laminin_aI | 1.81e-09 | 5 | 83 | 4 | IPR009254 | |
| Domain | Laminin_I | 1.81e-09 | 5 | 83 | 4 | PF06008 | |
| Domain | Laminin_II | 1.81e-09 | 5 | 83 | 4 | PF06009 | |
| Domain | Laminin_domII | 1.81e-09 | 5 | 83 | 4 | IPR010307 | |
| Domain | Laminin_N | 6.45e-09 | 16 | 83 | 5 | IPR008211 | |
| Domain | LAMININ_NTER | 6.45e-09 | 16 | 83 | 5 | PS51117 | |
| Domain | Laminin_N | 6.45e-09 | 16 | 83 | 5 | PF00055 | |
| Domain | LamNT | 6.45e-09 | 16 | 83 | 5 | SM00136 | |
| Domain | Galactose-bd-like | 8.80e-09 | 94 | 83 | 8 | IPR008979 | |
| Domain | TGFb_propeptide | 1.39e-07 | 28 | 83 | 5 | PF00688 | |
| Domain | TGF-b_N | 1.39e-07 | 28 | 83 | 5 | IPR001111 | |
| Domain | TGF-beta-rel | 2.81e-07 | 32 | 83 | 5 | IPR015615 | |
| Domain | TGFb_CS | 2.81e-07 | 32 | 83 | 5 | IPR017948 | |
| Domain | TGFB | 5.98e-07 | 37 | 83 | 5 | SM00204 | |
| Domain | TGF-b_C | 5.98e-07 | 37 | 83 | 5 | IPR001839 | |
| Domain | TGF_BETA_2 | 5.98e-07 | 37 | 83 | 5 | PS51362 | |
| Domain | TGF_beta | 5.98e-07 | 37 | 83 | 5 | PF00019 | |
| Domain | TGF_BETA_1 | 5.98e-07 | 37 | 83 | 5 | PS00250 | |
| Domain | TB | 2.92e-06 | 7 | 83 | 3 | PF00683 | |
| Domain | - | 4.66e-06 | 8 | 83 | 3 | 3.90.290.10 | |
| Domain | cEGF | 5.03e-06 | 26 | 83 | 4 | IPR026823 | |
| Domain | cEGF | 5.03e-06 | 26 | 83 | 4 | PF12662 | |
| Domain | EGF_extracell | 6.92e-06 | 60 | 83 | 5 | IPR013111 | |
| Domain | EGF_2 | 6.92e-06 | 60 | 83 | 5 | PF07974 | |
| Domain | TB | 6.97e-06 | 9 | 83 | 3 | PS51364 | |
| Domain | TB_dom | 6.97e-06 | 9 | 83 | 3 | IPR017878 | |
| Domain | FIBRINOGEN_C_1 | 1.19e-05 | 32 | 83 | 4 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.19e-05 | 32 | 83 | 4 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.19e-05 | 32 | 83 | 4 | PS51406 | |
| Domain | - | 1.19e-05 | 67 | 83 | 5 | 2.10.90.10 | |
| Domain | Cystine-knot_cytokine | 1.19e-05 | 67 | 83 | 5 | IPR029034 | |
| Domain | Fol_N | 1.36e-05 | 11 | 83 | 3 | IPR003645 | |
| Domain | - | 1.36e-05 | 11 | 83 | 3 | 2.40.155.10 | |
| Domain | GFP-like | 1.36e-05 | 11 | 83 | 3 | IPR023413 | |
| Domain | FOLN | 1.36e-05 | 11 | 83 | 3 | SM00274 | |
| Domain | HYR | 5.84e-05 | 3 | 83 | 2 | PS50825 | |
| Domain | HYR | 5.84e-05 | 3 | 83 | 2 | PF02494 | |
| Domain | GlyclTrfase_18 | 5.84e-05 | 3 | 83 | 2 | IPR026116 | |
| Domain | HYR_dom | 5.84e-05 | 3 | 83 | 2 | IPR003410 | |
| Domain | CCP | 9.68e-05 | 54 | 83 | 4 | SM00032 | |
| Domain | FA58C | 1.06e-04 | 21 | 83 | 3 | SM00231 | |
| Domain | FA58C_3 | 1.06e-04 | 21 | 83 | 3 | PS50022 | |
| Domain | FA58C_1 | 1.06e-04 | 21 | 83 | 3 | PS01285 | |
| Domain | FA58C_2 | 1.06e-04 | 21 | 83 | 3 | PS01286 | |
| Domain | SUSHI | 1.12e-04 | 56 | 83 | 4 | PS50923 | |
| Domain | VWA | 1.12e-04 | 56 | 83 | 4 | PF00092 | |
| Domain | Sushi_SCR_CCP_dom | 1.20e-04 | 57 | 83 | 4 | IPR000436 | |
| Domain | F5_F8_type_C | 1.60e-04 | 24 | 83 | 3 | PF00754 | |
| Domain | FA58C | 1.60e-04 | 24 | 83 | 3 | IPR000421 | |
| Domain | NIDO_dom | 1.93e-04 | 5 | 83 | 2 | IPR003886 | |
| Domain | NIDO | 1.93e-04 | 5 | 83 | 2 | SM00539 | |
| Domain | NIDO | 1.93e-04 | 5 | 83 | 2 | PF06119 | |
| Domain | NIDO | 1.93e-04 | 5 | 83 | 2 | PS51220 | |
| Domain | FBG | 2.84e-04 | 29 | 83 | 3 | SM00186 | |
| Domain | - | 3.15e-04 | 30 | 83 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 3.15e-04 | 30 | 83 | 3 | IPR014716 | |
| Domain | VWFA | 4.87e-04 | 82 | 83 | 4 | PS50234 | |
| Domain | VWA | 5.34e-04 | 84 | 83 | 4 | SM00327 | |
| Domain | LDLR_class-A_CS | 7.43e-04 | 40 | 83 | 3 | IPR023415 | |
| Domain | VWF_A | 9.91e-04 | 99 | 83 | 4 | IPR002035 | |
| Domain | Ldl_recept_a | 1.05e-03 | 45 | 83 | 3 | PF00057 | |
| Domain | - | 1.12e-03 | 46 | 83 | 3 | 4.10.400.10 | |
| Domain | EGF_3 | 1.25e-03 | 12 | 83 | 2 | PF12947 | |
| Domain | EGF_dom | 1.25e-03 | 12 | 83 | 2 | IPR024731 | |
| Domain | LDLRA_1 | 1.27e-03 | 48 | 83 | 3 | PS01209 | |
| Domain | LDLRA_2 | 1.35e-03 | 49 | 83 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.35e-03 | 49 | 83 | 3 | IPR002172 | |
| Domain | LDLa | 1.35e-03 | 49 | 83 | 3 | SM00192 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | BMP1 HSPG2 BMP7 FBLN1 FBN2 MATN3 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 FGG ITGAM LTBP4 | 3.90e-13 | 300 | 66 | 16 | M610 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 6.65e-11 | 30 | 66 | 7 | M27216 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 8.72e-10 | 11 | 66 | 5 | M158 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.23e-08 | 66 | 66 | 7 | M18 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.03e-08 | 76 | 66 | 7 | M27219 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.51e-07 | 30 | 66 | 5 | M27772 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.10e-07 | 59 | 66 | 6 | M27218 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 4.14e-07 | 33 | 66 | 5 | M39503 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST | 5.75e-07 | 15 | 66 | 4 | M47824 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 7.49e-07 | 37 | 66 | 5 | M27134 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.27e-06 | 41 | 66 | 5 | M27778 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.78e-06 | 79 | 66 | 6 | M27643 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.82e-06 | 44 | 66 | 5 | M26969 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY | 2.01e-06 | 20 | 66 | 4 | M47843 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 2.28e-06 | 46 | 66 | 5 | M239 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.55e-06 | 84 | 66 | 6 | M7098 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.98e-06 | 258 | 66 | 9 | MM14572 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.92e-06 | 140 | 66 | 7 | M587 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 8.63e-06 | 60 | 66 | 5 | M40048 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.38e-05 | 66 | 66 | 5 | MM15925 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.43e-05 | 32 | 66 | 4 | MM14854 | |
| Pathway | WP_FOCAL_ADHESION | 2.60e-05 | 187 | 66 | 7 | MM15913 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.19e-05 | 39 | 66 | 4 | MM14601 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 4.48e-05 | 84 | 66 | 5 | M3228 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 8.49e-05 | 96 | 66 | 5 | M39834 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 1.34e-04 | 56 | 66 | 4 | M1053 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.83e-04 | 124 | 66 | 5 | M27285 | |
| Pathway | WP_FOCAL_ADHESION | 3.30e-04 | 199 | 66 | 6 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.30e-04 | 199 | 66 | 6 | M7253 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 4.01e-04 | 31 | 66 | 3 | MM1343 | |
| Pathway | BIOCARTA_ALK_PATHWAY | 6.80e-04 | 37 | 66 | 3 | M17400 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 6.98e-04 | 86 | 66 | 4 | M2642 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.05e-03 | 96 | 66 | 4 | M39581 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 1.16e-03 | 11 | 66 | 2 | MM1436 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 1.16e-03 | 11 | 66 | 2 | M4956 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 1.38e-03 | 12 | 66 | 2 | M22020 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 1.38e-03 | 12 | 66 | 2 | M2842 | |
| Pathway | BIOCARTA_GRANULOCYTES_PATHWAY | 2.18e-03 | 15 | 66 | 2 | M5467 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.18e-03 | 15 | 66 | 2 | M27161 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.40e-03 | 120 | 66 | 4 | MM14982 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 3.20e-03 | 130 | 66 | 4 | MM15455 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 3.38e-03 | 132 | 66 | 4 | M724 | |
| Pubmed | HSPG2 FBLN1 FRAS1 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 FGG LTBP4 ITIH2 | 2.46e-16 | 167 | 85 | 13 | 22159717 | |
| Pubmed | SLIT2 BMP1 HSPG2 FBN2 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 FGG LTBP4 | 4.55e-16 | 175 | 85 | 13 | 28071719 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 2.56e-15 | 15 | 85 | 7 | 15895400 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | SLIT2 BMP1 HSPG2 FBLN1 GAS6 LAMA1 LAMA2 LAMB1 NID1 LTBP2 LTBP4 ITIH2 SVEP1 | 4.21e-14 | 248 | 85 | 13 | 24006456 |
| Pubmed | 7.74e-14 | 5 | 85 | 5 | 11829758 | ||
| Pubmed | 1.63e-13 | 12 | 85 | 6 | 16750824 | ||
| Pubmed | 3.01e-13 | 13 | 85 | 6 | 12682087 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 3.60e-13 | 79 | 85 | 9 | 18757743 | |
| Pubmed | 5.26e-13 | 14 | 85 | 6 | 19783738 | ||
| Pubmed | 6.05e-13 | 29 | 85 | 7 | 22613833 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.35e-12 | 135 | 85 | 10 | 28675934 | |
| Pubmed | 2.97e-12 | 146 | 85 | 10 | 27068509 | ||
| Pubmed | 4.31e-12 | 8 | 85 | 5 | 8872465 | ||
| Pubmed | 4.76e-12 | 153 | 85 | 10 | 25037231 | ||
| Pubmed | 7.07e-12 | 40 | 85 | 7 | 27068110 | ||
| Pubmed | 1.93e-11 | 10 | 85 | 5 | 9034910 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 1.93e-11 | 10 | 85 | 5 | 16100707 | |
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 1.93e-11 | 10 | 85 | 5 | 16554364 | |
| Pubmed | 3.53e-11 | 11 | 85 | 5 | 12051813 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 3.53e-11 | 11 | 85 | 5 | 21524702 | |
| Pubmed | 6.05e-11 | 12 | 85 | 5 | 9396756 | ||
| Pubmed | 1.66e-10 | 5 | 85 | 4 | 11969289 | ||
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 1.66e-10 | 5 | 85 | 4 | 9415429 | |
| Pubmed | Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections. | 1.66e-10 | 5 | 85 | 4 | 8613743 | |
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 1.66e-10 | 5 | 85 | 4 | 9389447 | |
| Pubmed | 2.28e-10 | 15 | 85 | 5 | 10625553 | ||
| Pubmed | 2.28e-10 | 15 | 85 | 5 | 9264260 | ||
| Pubmed | 3.31e-10 | 16 | 85 | 5 | 17601529 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 3.90e-10 | 37 | 85 | 6 | 34323105 | |
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 1678389 | ||
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 4.96e-10 | 6 | 85 | 4 | 23948589 | |
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 2119632 | ||
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 9597096 | ||
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 7605753 | ||
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 4.96e-10 | 6 | 85 | 4 | 3794389 | |
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 4.96e-10 | 6 | 85 | 4 | 3109910 | |
| Pubmed | 6.47e-10 | 18 | 85 | 5 | 14730302 | ||
| Pubmed | 6.47e-10 | 18 | 85 | 5 | 11311202 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 6.47e-10 | 18 | 85 | 5 | 39040056 | |
| Pubmed | 1.16e-09 | 7 | 85 | 4 | 14557481 | ||
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 1.16e-09 | 7 | 85 | 4 | 9390664 | |
| Pubmed | 1.17e-09 | 20 | 85 | 5 | 22911573 | ||
| Pubmed | 1.97e-09 | 22 | 85 | 5 | 28334989 | ||
| Pubmed | 2.31e-09 | 8 | 85 | 4 | 12015298 | ||
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 2.31e-09 | 8 | 85 | 4 | 9489770 | |
| Pubmed | 2.31e-09 | 8 | 85 | 4 | 9852162 | ||
| Pubmed | 2.60e-09 | 50 | 85 | 6 | 23658023 | ||
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 3.96e-09 | 25 | 85 | 5 | 19373938 | |
| Pubmed | 4.15e-09 | 9 | 85 | 4 | 15102706 | ||
| Pubmed | 4.15e-09 | 9 | 85 | 4 | 1460021 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.35e-09 | 97 | 85 | 7 | 27559042 | |
| Pubmed | 4.89e-09 | 26 | 85 | 5 | 24742657 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 4.89e-09 | 26 | 85 | 5 | 34189436 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | HSPG2 FBLN1 FAT4 MGAT5 FCGBP SPINT1 GAS6 LAMA3 LAMA5 NID1 CPB2 LTBP2 FGG ITGAM DNASE1 ITIH2 | 6.20e-09 | 1070 | 85 | 16 | 23533145 |
| Pubmed | 6.90e-09 | 10 | 85 | 4 | 22911783 | ||
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 6.90e-09 | 10 | 85 | 4 | 18590826 | |
| Pubmed | 6.90e-09 | 10 | 85 | 4 | 11784026 | ||
| Pubmed | Primary cellular meningeal defects cause neocortical dysplasia and dyslamination. | 6.90e-09 | 10 | 85 | 4 | 20976766 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.08e-08 | 11 | 85 | 4 | 23472759 | |
| Pubmed | 1.19e-08 | 64 | 85 | 6 | 22261194 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 8354280 | ||
| Pubmed | Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis. | 1.41e-08 | 3 | 85 | 3 | 11784057 | |
| Pubmed | Large-scale identification of genes implicated in kidney glomerulus development and function. | 2.04e-08 | 34 | 85 | 5 | 16498405 | |
| Pubmed | PHKA2 HSPG2 USP13 FBLN1 FBN2 SPINT1 ZNF592 LAMA5 NID1 ZYX SVEP1 ZNF518A | 2.21e-08 | 591 | 85 | 12 | 15231748 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 2.34e-08 | 13 | 85 | 4 | 9833687 | |
| Pubmed | 2.34e-08 | 13 | 85 | 4 | 36350252 | ||
| Pubmed | Bmp7 regulates germ cell proliferation in mouse fetal gonads. | 2.34e-08 | 13 | 85 | 4 | 18391523 | |
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 2.34e-08 | 13 | 85 | 4 | 21900571 | |
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 3.26e-08 | 14 | 85 | 4 | 20858856 | |
| Pubmed | 3.26e-08 | 14 | 85 | 4 | 9151674 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 4.44e-08 | 15 | 85 | 4 | 12921739 | |
| Pubmed | Expression of laminin chains by central neurons: analysis with gene and protein trapping techniques. | 5.63e-08 | 4 | 85 | 3 | 12820173 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 9299121 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 9885251 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 17676646 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 9201115 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 2099832 | ||
| Pubmed | Role of mesenchymal nidogen for epithelial morphogenesis in vitro. | 5.63e-08 | 4 | 85 | 3 | 7925005 | |
| Pubmed | Role of laminin terminal globular domains in basement membrane assembly. | 5.63e-08 | 4 | 85 | 3 | 17517882 | |
| Pubmed | Laminin-1 reexpression in Alport mouse glomerular basement membranes. | 5.63e-08 | 4 | 85 | 3 | 12631063 | |
| Pubmed | 5.91e-08 | 16 | 85 | 4 | 11564885 | ||
| Pubmed | 5.91e-08 | 16 | 85 | 4 | 30579834 | ||
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 5.91e-08 | 16 | 85 | 4 | 17948866 | |
| Pubmed | 5.91e-08 | 16 | 85 | 4 | 16880404 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 7.16e-08 | 86 | 85 | 6 | 28327460 | |
| Pubmed | 7.72e-08 | 17 | 85 | 4 | 21983115 | ||
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 7.72e-08 | 17 | 85 | 4 | 15056720 | |
| Pubmed | Dysfunction of programmed embryo senescence is linked to genetic developmental defects. | 9.90e-08 | 18 | 85 | 4 | 37017267 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 8286607 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 10964500 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 9719032 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 12743034 | ||
| Pubmed | Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. | 1.40e-07 | 5 | 85 | 3 | 8719886 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 1725162 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 8359228 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 7516699 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 9647658 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 7851641 | ||
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 1.50e-07 | 50 | 85 | 5 | 24191021 | |
| Interaction | FBXO2 interactions | SNED1 SLIT2 BMP1 CNTNAP3B HSPG2 FRAS1 FBN2 SPINT1 CNTNAP1 GAS6 LAMA1 CNTNAP3 LAMA3 LAMA5 LAMB1 NID1 LTBP4 | 9.63e-13 | 411 | 84 | 17 | int:FBXO2 |
| Interaction | CFC1 interactions | BMP1 CNTNAP3B FRAS1 MGAT5 SPINT1 CNTNAP1 CNTNAP3 LAMA5 LAMB1 BMP8A LTBP4 | 4.62e-12 | 126 | 84 | 11 | int:CFC1 |
| Interaction | PRG2 interactions | BMP1 CNTNAP3B HSPG2 FRAS1 MGAT5 FBN2 SPINT1 PATZ1 GAS6 CNTNAP3 DVL2 LAMA5 BMP8A LTBP4 | 1.22e-11 | 285 | 84 | 14 | int:PRG2 |
| Interaction | IGFL3 interactions | 8.71e-10 | 75 | 84 | 8 | int:IGFL3 | |
| Interaction | LY86 interactions | BMP1 CNTNAP3B FBLN1 MGAT5 SPINT1 CNTNAP1 GAS6 CNTNAP3 LAMA5 LAMB1 BMP8A | 1.63e-09 | 217 | 84 | 11 | int:LY86 |
| Interaction | SLURP1 interactions | 8.82e-09 | 144 | 84 | 9 | int:SLURP1 | |
| Interaction | SDF2L1 interactions | BMP1 CNTNAP3B HSPG2 FRAS1 MGAT5 SPINT1 CNTNAP1 GAS6 CNTNAP3 LAMA5 LAMB1 BMP8A | 9.12e-09 | 322 | 84 | 12 | int:SDF2L1 |
| Interaction | CEACAM8 interactions | 3.49e-08 | 119 | 84 | 8 | int:CEACAM8 | |
| Interaction | LLCFC1 interactions | 3.98e-08 | 121 | 84 | 8 | int:LLCFC1 | |
| Interaction | GPIHBP1 interactions | 8.33e-08 | 133 | 84 | 8 | int:GPIHBP1 | |
| Interaction | DEFA1 interactions | 1.98e-07 | 100 | 84 | 7 | int:DEFA1 | |
| Interaction | FBLN2 interactions | 3.25e-07 | 66 | 84 | 6 | int:FBLN2 | |
| Interaction | C1QTNF7 interactions | 4.25e-07 | 69 | 84 | 6 | int:C1QTNF7 | |
| Interaction | C1orf54 interactions | 4.80e-07 | 167 | 84 | 8 | int:C1orf54 | |
| Interaction | FIBIN interactions | 5.05e-07 | 71 | 84 | 6 | int:FIBIN | |
| Interaction | PDGFRA interactions | SLIT2 BMP1 CNTNAP3B BMP7 BMP8B MGAT5 LAMA1 CNTNAP3 LAMA5 LAMB1 BMP8A | 5.72e-07 | 385 | 84 | 11 | int:PDGFRA |
| Interaction | PTPRK interactions | 7.46e-07 | 177 | 84 | 8 | int:PTPRK | |
| Interaction | CCL3 interactions | 7.79e-07 | 178 | 84 | 8 | int:CCL3 | |
| Interaction | CRP interactions | 8.19e-07 | 77 | 84 | 6 | int:CRP | |
| Interaction | ZNF707 interactions | 9.54e-07 | 79 | 84 | 6 | int:ZNF707 | |
| Interaction | NOTCH2 interactions | SLIT2 FBLN1 FBN2 ZNF592 PATZ1 DLK1 DLL1 ZNF865 LTBP4 ZYX ZNF518A | 1.44e-06 | 423 | 84 | 11 | int:NOTCH2 |
| Interaction | ZNF408 interactions | 2.46e-06 | 145 | 84 | 7 | int:ZNF408 | |
| Interaction | MFAP5 interactions | 2.49e-06 | 52 | 84 | 5 | int:MFAP5 | |
| Interaction | C1QB interactions | 2.66e-06 | 94 | 84 | 6 | int:C1QB | |
| Interaction | TRGV3 interactions | 3.29e-06 | 55 | 84 | 5 | int:TRGV3 | |
| Interaction | OS9 interactions | 3.67e-06 | 219 | 84 | 8 | int:OS9 | |
| Interaction | SCGB2A2 interactions | 4.20e-06 | 223 | 84 | 8 | int:SCGB2A2 | |
| Interaction | GML interactions | 4.30e-06 | 58 | 84 | 5 | int:GML | |
| Interaction | FBLN5 interactions | 4.54e-06 | 159 | 84 | 7 | int:FBLN5 | |
| Interaction | ELN interactions | 6.16e-06 | 29 | 84 | 4 | int:ELN | |
| Interaction | LAMC2 interactions | 7.09e-06 | 30 | 84 | 4 | int:LAMC2 | |
| Interaction | IL5RA interactions | 1.32e-05 | 124 | 84 | 6 | int:IL5RA | |
| Interaction | CST11 interactions | 1.53e-05 | 75 | 84 | 5 | int:CST11 | |
| Interaction | ST14 interactions | 2.53e-05 | 207 | 84 | 7 | int:ST14 | |
| Interaction | TAFAZZIN interactions | 2.53e-05 | 207 | 84 | 7 | int:TAFAZZIN | |
| Interaction | NID2 interactions | 2.98e-05 | 86 | 84 | 5 | int:NID2 | |
| Interaction | SIRPD interactions | 2.98e-05 | 86 | 84 | 5 | int:SIRPD | |
| Interaction | FGF4 interactions | 3.36e-05 | 44 | 84 | 4 | int:FGF4 | |
| Interaction | BTNL2 interactions | 4.66e-05 | 155 | 84 | 6 | int:BTNL2 | |
| Interaction | NID1 interactions | 4.75e-05 | 48 | 84 | 4 | int:NID1 | |
| Interaction | PRG3 interactions | 5.16e-05 | 49 | 84 | 4 | int:PRG3 | |
| Interaction | HSPG2 interactions | 5.59e-05 | 98 | 84 | 5 | int:HSPG2 | |
| Interaction | FBN1 interactions | 6.04e-05 | 51 | 84 | 4 | int:FBN1 | |
| Interaction | DEFB125 interactions | 7.57e-05 | 20 | 84 | 3 | int:DEFB125 | |
| Interaction | ZNF444 interactions | 8.13e-05 | 106 | 84 | 5 | int:ZNF444 | |
| Interaction | EDN3 interactions | 8.88e-05 | 108 | 84 | 5 | int:EDN3 | |
| Interaction | ZFP41 interactions | 9.38e-05 | 57 | 84 | 4 | int:ZFP41 | |
| Interaction | NXPH3 interactions | 1.00e-04 | 58 | 84 | 4 | int:NXPH3 | |
| Interaction | ADAMTSL2 interactions | 1.02e-04 | 4 | 84 | 2 | int:ADAMTSL2 | |
| Interaction | NTN5 interactions | 1.33e-04 | 24 | 84 | 3 | int:NTN5 | |
| Interaction | COL7A1 interactions | 1.50e-04 | 25 | 84 | 3 | int:COL7A1 | |
| Interaction | OIT3 interactions | 1.57e-04 | 65 | 84 | 4 | int:OIT3 | |
| Interaction | CACNA1A interactions | 1.64e-04 | 123 | 84 | 5 | int:CACNA1A | |
| Interaction | LAMA1 interactions | 1.66e-04 | 66 | 84 | 4 | int:LAMA1 | |
| Interaction | CXCL5 interactions | 1.90e-04 | 27 | 84 | 3 | int:CXCL5 | |
| Interaction | CBLN4 interactions | 1.90e-04 | 127 | 84 | 5 | int:CBLN4 | |
| Interaction | FBLN1 interactions | 2.05e-04 | 129 | 84 | 5 | int:FBLN1 | |
| Interaction | CDH23 interactions | 2.21e-04 | 71 | 84 | 4 | int:CDH23 | |
| Interaction | PLAUR interactions | 2.53e-04 | 135 | 84 | 5 | int:PLAUR | |
| Interaction | COL4A3 interactions | 2.61e-04 | 30 | 84 | 3 | int:COL4A3 | |
| Interaction | GFI1B interactions | 2.62e-04 | 136 | 84 | 5 | int:GFI1B | |
| Interaction | ISLR interactions | 2.80e-04 | 138 | 84 | 5 | int:ISLR | |
| Interaction | CST9L interactions | 3.17e-04 | 78 | 84 | 4 | int:CST9L | |
| Interaction | PRELP interactions | 3.18e-04 | 32 | 84 | 3 | int:PRELP | |
| Interaction | NXPH2 interactions | 3.48e-04 | 33 | 84 | 3 | int:NXPH2 | |
| Interaction | PI15 interactions | 4.02e-04 | 83 | 84 | 4 | int:PI15 | |
| Interaction | LYZL2 interactions | 4.40e-04 | 85 | 84 | 4 | int:LYZL2 | |
| Interaction | LTBP2 interactions | 4.40e-04 | 85 | 84 | 4 | int:LTBP2 | |
| Interaction | BCAN interactions | 4.52e-04 | 36 | 84 | 3 | int:BCAN | |
| Interaction | GGH interactions | 5.36e-04 | 243 | 84 | 6 | int:GGH | |
| Interaction | ELSPBP1 interactions | 5.94e-04 | 92 | 84 | 4 | int:ELSPBP1 | |
| Interaction | COL27A1 interactions | 6.06e-04 | 9 | 84 | 2 | int:COL27A1 | |
| Interaction | CHRDL2 interactions | 6.17e-04 | 40 | 84 | 3 | int:CHRDL2 | |
| Interaction | RLN1 interactions | 6.18e-04 | 93 | 84 | 4 | int:RLN1 | |
| Interaction | PSG8 interactions | 6.64e-04 | 41 | 84 | 3 | int:PSG8 | |
| Interaction | CLEC11A interactions | 6.97e-04 | 96 | 84 | 4 | int:CLEC11A | |
| Interaction | PYHIN1 interactions | 7.38e-04 | 358 | 84 | 7 | int:PYHIN1 | |
| Interaction | FBXO6 interactions | CNTNAP3B HSPG2 FBLN1 FRAS1 FBN2 CNTNAP1 LAMA3 LAMA5 LAMB1 LTBP4 | 7.84e-04 | 717 | 84 | 10 | int:FBXO6 |
| Interaction | NOG interactions | 8.74e-04 | 45 | 84 | 3 | int:NOG | |
| Interaction | CMA1 interactions | 9.32e-04 | 46 | 84 | 3 | int:CMA1 | |
| Interaction | PLG interactions | 1.01e-03 | 106 | 84 | 4 | int:PLG | |
| Interaction | ACHE interactions | 1.10e-03 | 12 | 84 | 2 | int:ACHE | |
| Interaction | ATN1 interactions | 1.11e-03 | 187 | 84 | 5 | int:ATN1 | |
| Interaction | SUSD4 interactions | 1.19e-03 | 50 | 84 | 3 | int:SUSD4 | |
| Interaction | CNTNAP3B interactions | 1.19e-03 | 50 | 84 | 3 | int:CNTNAP3B | |
| Interaction | DKKL1 interactions | 1.20e-03 | 111 | 84 | 4 | int:DKKL1 | |
| Interaction | BMP1 interactions | 1.20e-03 | 111 | 84 | 4 | int:BMP1 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 1.30e-10 | 11 | 58 | 5 | 455 | |
| GeneFamily | Laminin subunits | 2.22e-10 | 12 | 58 | 5 | 626 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.32e-05 | 57 | 58 | 4 | 1179 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 6.04e-05 | 4 | 58 | 2 | 628 | |
| GeneFamily | Endogenous ligands | 1.09e-04 | 237 | 58 | 6 | 542 | |
| GeneFamily | Mannosyl-glycoprotein N-acetylglucosaminyltransferases | 3.59e-04 | 9 | 58 | 2 | 435 | |
| GeneFamily | Gla domain containing | 7.71e-04 | 13 | 58 | 2 | 1250 | |
| GeneFamily | LIM domain containing | 8.97e-04 | 59 | 58 | 3 | 1218 | |
| GeneFamily | PRAME family | 2.67e-03 | 24 | 58 | 2 | 686 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 7.83e-03 | 718 | 58 | 7 | 28 | |
| GeneFamily | PDZ domain containing | 1.28e-02 | 152 | 58 | 3 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 1.47e-02 | 160 | 58 | 3 | 555 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SNED1 SLIT2 FBLN1 FRAS1 FBN2 MATN3 GAS6 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 SRPX FGG LTBP4 SVEP1 | 1.17e-21 | 191 | 85 | 18 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SNED1 SLIT2 FBLN1 FRAS1 FBN2 MATN3 GAS6 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 SRPX FGG LTBP4 SVEP1 | 1.88e-21 | 196 | 85 | 18 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | SNED1 SLIT2 HSPG2 FBLN1 FRAS1 FBN2 MATN3 GAS6 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 SRPX FGG LTBP4 SVEP1 | 2.15e-20 | 270 | 85 | 19 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | SNED1 SLIT2 HSPG2 FBLN1 FRAS1 FBN2 MATN3 GAS6 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 SRPX FGG LTBP4 SVEP1 | 3.05e-20 | 275 | 85 | 19 | M5884 |
| Coexpression | NABA_MATRISOME | SNED1 SLIT2 BMP1 HSPG2 BMP5 BMP7 FBLN1 BMP8B FRAS1 FBN2 CRLF3 MATN3 GAS6 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 SRPX BMP8A FGG GDF10 LTBP4 MEGF11 ITIH2 SVEP1 | 4.66e-19 | 1008 | 85 | 28 | MM17056 |
| Coexpression | NABA_MATRISOME | SNED1 SLIT2 BMP1 HSPG2 BMP5 BMP7 FBLN1 BMP8B FRAS1 FBN2 CRLF3 MATN3 GAS6 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 LTBP2 SRPX BMP8A FGG GDF10 LTBP4 MEGF11 ITIH2 SVEP1 | 7.40e-19 | 1026 | 85 | 28 | M5889 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.01e-11 | 40 | 85 | 7 | M5887 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | SLIT2 BMP1 HSPG2 BMP7 PRICKLE1 MICAL2 PLCH2 LAMA1 LAMA3 LAMB1 SRPX DLL1 LTBP4 SVEP1 | 4.46e-10 | 479 | 85 | 14 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | SLIT2 BMP1 HSPG2 BMP7 PRICKLE1 MICAL2 PLCH2 LAMA1 LAMA3 LAMB1 SRPX DLL1 LTBP4 SVEP1 | 4.97e-10 | 483 | 85 | 14 | MM1082 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.02e-08 | 23 | 85 | 5 | M48001 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 9.57e-08 | 35 | 85 | 5 | MM17054 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.91e-07 | 200 | 85 | 8 | M5930 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 4.80e-07 | 20 | 85 | 4 | MM17053 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 6.01e-07 | 50 | 85 | 5 | MM403 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | SLIT2 BMP5 FRAS1 SPINT1 PATZ1 GAS6 ELAPOR1 LAMA2 LHFPL2 SRPX | 1.54e-06 | 437 | 85 | 10 | M1610 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN | 1.94e-06 | 179 | 85 | 7 | M8519 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | SLIT2 BMP5 FRAS1 SPINT1 PATZ1 GAS6 ELAPOR1 LAMA2 LHFPL2 SRPX | 2.20e-06 | 455 | 85 | 10 | MM1189 |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 2.28e-06 | 117 | 85 | 6 | M39300 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 3.68e-06 | 482 | 85 | 10 | M12144 | |
| Coexpression | WANG_MLL_TARGETS | 5.19e-06 | 294 | 85 | 8 | M2456 | |
| Coexpression | WANG_MLL_TARGETS | 6.95e-06 | 306 | 85 | 8 | MM1076 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 1.46e-05 | 15 | 85 | 3 | MM402 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 1.59e-05 | 164 | 85 | 6 | M41676 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 1.70e-05 | 166 | 85 | 6 | M1542 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 1.79e-05 | 99 | 85 | 5 | M39152 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 2.07e-05 | 257 | 85 | 7 | M13867 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.28e-05 | 261 | 85 | 7 | M1834 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 2.61e-05 | 179 | 85 | 6 | MM660 | |
| Coexpression | CYCLIN_D1_UP.V1_UP | 3.33e-05 | 187 | 85 | 6 | M2654 | |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | 3.42e-05 | 382 | 85 | 8 | M38972 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 3.62e-05 | 385 | 85 | 8 | M39264 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | SLIT2 HSPG2 BMP5 FBLN1 PTPRM MATN3 GAS6 NID1 LTBP2 SRPX SVEP1 | 3.73e-05 | 767 | 85 | 11 | M39209 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | 3.77e-05 | 504 | 85 | 9 | M2157 | |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_DN | 4.90e-05 | 122 | 85 | 5 | M10276 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_DN | 6.88e-05 | 213 | 85 | 6 | M12176 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 7.11e-05 | 681 | 85 | 10 | M39175 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 8.50e-05 | 137 | 85 | 5 | M40313 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.13e-04 | 29 | 85 | 3 | MM17055 | |
| Coexpression | NABA_SECRETED_FACTORS | 1.16e-04 | 338 | 85 | 7 | MM17064 | |
| Coexpression | WONG_ENDMETRIUM_CANCER_DN | 1.22e-04 | 78 | 85 | 4 | M1311 | |
| Coexpression | FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP | 1.22e-04 | 78 | 85 | 4 | M4605 | |
| Coexpression | NABA_SECRETED_FACTORS | 1.27e-04 | 343 | 85 | 7 | M5883 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.49e-04 | 352 | 85 | 7 | M17471 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 1.57e-04 | 156 | 85 | 5 | MM550 | |
| Coexpression | DESCARTES_FETAL_LIVER_STELLATE_CELLS | 1.76e-04 | 160 | 85 | 5 | M40233 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 1.87e-04 | 162 | 85 | 5 | M45037 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 2.01e-04 | 493 | 85 | 8 | M1951 | |
| Coexpression | LIU_VAV3_PROSTATE_CARCINOGENESIS_UP | 2.04e-04 | 89 | 85 | 4 | M215 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 2.33e-04 | 504 | 85 | 8 | MM830 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 2.51e-04 | 94 | 85 | 4 | M2580 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 2.62e-04 | 95 | 85 | 4 | MM1328 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPITHELIAL_CELLS | 2.67e-04 | 175 | 85 | 5 | MM3643 | |
| Coexpression | GYORFFY_DOXORUBICIN_RESISTANCE | 2.76e-04 | 39 | 85 | 3 | M1987 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3 | 2.87e-04 | 8 | 85 | 2 | M10331 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3 | 3.69e-04 | 9 | 85 | 2 | MM608 | |
| Coexpression | WIERENGA_STAT5A_TARGETS_DN | 4.18e-04 | 193 | 85 | 5 | M2213 | |
| Coexpression | DURAND_STROMA_S_UP | 4.38e-04 | 300 | 85 | 6 | M2581 | |
| Coexpression | GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN | 4.49e-04 | 196 | 85 | 5 | M8422 | |
| Coexpression | GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN | 4.59e-04 | 197 | 85 | 5 | M7258 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 4.62e-04 | 303 | 85 | 6 | M39040 | |
| Coexpression | DURAND_STROMA_S_UP | 4.70e-04 | 304 | 85 | 6 | MM1083 | |
| Coexpression | GSE3039_NKT_CELL_VS_B1_BCELL_UP | 4.81e-04 | 199 | 85 | 5 | M6432 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP | 4.81e-04 | 199 | 85 | 5 | M5384 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 4.81e-04 | 199 | 85 | 5 | M7420 | |
| Coexpression | GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN | 4.92e-04 | 200 | 85 | 5 | M6567 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 5.10e-04 | 567 | 85 | 8 | M2129 | |
| Coexpression | CERVERA_SDHB_TARGETS_2 | 5.41e-04 | 115 | 85 | 4 | M19068 | |
| Coexpression | DESCARTES_FETAL_STOMACH_STROMAL_CELLS | 5.78e-04 | 50 | 85 | 3 | M40304 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 6.47e-04 | 738 | 85 | 9 | MM17058 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_MESENCHYMAL | 6.97e-04 | 216 | 85 | 5 | M2122 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 7.24e-04 | 54 | 85 | 3 | M4737 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 7.33e-04 | 751 | 85 | 9 | M5885 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 7.41e-04 | 125 | 85 | 4 | M1320 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_BRAIN_LIVER_LUNG_METASTASTASES | 7.92e-04 | 13 | 85 | 2 | M48004 | |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN | 7.92e-04 | 13 | 85 | 2 | M27964 | |
| Coexpression | DESCARTES_FETAL_LUNG_STROMAL_CELLS | 8.06e-04 | 56 | 85 | 3 | M40248 | |
| Coexpression | PETROVA_PROX1_TARGETS_DN | 8.06e-04 | 56 | 85 | 3 | M1472 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | SNED1 SLIT2 BMP1 HSPG2 BMP5 FBLN1 GAS6 LAMA2 LAMB1 NID1 DLK1 SRPX LTBP4 SVEP1 | 1.22e-09 | 437 | 82 | 14 | GSM777046_500 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | SELP SLIT2 HSPG2 STAB2 PTPRM MICAL2 GAS6 LAMB1 LHFPL2 NID1 LTBP2 GDF10 LTBP4 | 1.29e-08 | 439 | 82 | 13 | GSM777059_500 |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | SELP HSPG2 FAT4 PTPRM GAS6 LAMA3 LAMA5 LAMB1 LHFPL2 NID1 LTBP2 DLL1 LTBP4 | 2.02e-08 | 456 | 82 | 13 | GSM777032_500 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | SELP HSPG2 FAT4 PTPRM LAMA3 LAMA5 LAMB1 LHFPL2 NID1 LTBP2 DLL1 LTBP4 | 1.90e-07 | 459 | 82 | 12 | GSM777037_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | BMP1 HSPG2 FBLN1 GAS6 LAMA2 LAMA5 LAMB1 NID1 SRPX GDF10 LTBP4 SVEP1 | 2.24e-07 | 466 | 82 | 12 | GSM777050_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | SLIT2 BMP5 FBLN1 FRAS1 FBN2 MICAL2 CYSLTR1 LAMA1 LAMA2 LAMB1 LHFPL2 NID1 DLK1 LTBP4 SVEP1 | 2.51e-07 | 777 | 82 | 15 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | SLIT2 FBLN1 MICAL2 LAMA1 LAMA2 LAMB1 LHFPL2 DLK1 LTBP4 SVEP1 | 6.72e-07 | 336 | 82 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | SLIT2 BMP1 HSPG2 FBLN1 GAS6 LAMA2 LAMB1 NID1 SRPX LTBP4 SVEP1 | 1.11e-06 | 445 | 82 | 11 | GSM777043_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.13e-06 | 356 | 82 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | SNED1 BMP1 HSPG2 FBLN1 GAS6 LAMB1 NID1 LTBP2 SRPX LTBP4 SVEP1 | 1.38e-06 | 455 | 82 | 11 | GSM777055_500 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.57e-06 | 369 | 82 | 10 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.06e-06 | 97 | 82 | 6 | GSM777043_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 2.42e-06 | 156 | 82 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.09e-06 | 310 | 82 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 3.51e-06 | 165 | 82 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.08e-06 | 337 | 82 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | HSPG2 FRAS1 SPINT1 MICAL2 MATN3 LAMA3 LAMB1 LTBP2 SRPX FGG PRAG1 ZYX ITIH2 | 6.62e-06 | 761 | 82 | 13 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 6.70e-06 | 182 | 82 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | SLIT2 BMP5 FBLN1 FBN2 MICAL2 LAMA1 LAMA2 LAMB1 LHFPL2 NID1 DLK1 LTBP4 SVEP1 | 7.83e-06 | 773 | 82 | 13 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 9.06e-06 | 450 | 82 | 10 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 9.60e-06 | 453 | 82 | 10 | GSM777067_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.06e-05 | 361 | 82 | 9 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.76e-05 | 293 | 82 | 8 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 2.29e-05 | 398 | 82 | 9 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 2.57e-05 | 404 | 82 | 9 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | SLIT2 BMP5 FBLN1 FBN2 MICAL2 LAMA1 LAMA2 LAMB1 NID1 DLK1 LTBP4 SVEP1 | 3.73e-05 | 768 | 82 | 12 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | SLIT2 BMP7 FBLN1 FRAS1 FBN2 SPINT1 LAMA1 ELAPOR1 LAMA5 LAMB1 CPB2 DLL1 | 4.50e-05 | 783 | 82 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | SLIT2 BMP1 BMP5 FBLN1 FAT4 FBN2 GAS6 LAMA1 LAMB1 LHFPL2 DLK1 LTBP4 | 5.34e-05 | 797 | 82 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | SNED1 CNTNAP3B HSPG2 FAT4 MPP4 MICAL2 CNTNAP1 ELAPOR1 CNTNAP3 LAMB1 NID1 LTBP2 SRPX | 5.79e-05 | 936 | 82 | 13 | JC_hmvEC_2500_K1 |
| CoexpressionAtlas | placenta | 6.08e-05 | 349 | 82 | 8 | placenta | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.46e-05 | 265 | 82 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.09e-04 | 195 | 82 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 1.43e-04 | 395 | 82 | 8 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.51e-04 | 207 | 82 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | FBLN1 FRAS1 GAS6 CNTNAP3 LAMA2 NID1 LTBP2 SRPX LTBP4 ITIH2 SVEP1 | 1.95e-04 | 778 | 82 | 11 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.01e-04 | 311 | 82 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SLIT2 BMP1 FBN2 PATZ1 LHFPL2 NID1 DLK1 SRPX GDF10 LTBP4 SVEP1 | 2.22e-04 | 790 | 82 | 11 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | SLIT2 BMP5 MICAL2 LAMA1 LAMA2 LAMB1 LHFPL2 NID1 DLK1 LTBP4 SVEP1 | 2.30e-04 | 793 | 82 | 11 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | SNED1 BMP1 HSPG2 FBLN1 FAT4 FBN2 PTPRM PRICKLE1 DVL2 LHFPL2 LTBP4 MAMDC4 DNASE1 SVEP1 | 2.37e-04 | 1228 | 82 | 14 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 2.39e-04 | 320 | 82 | 7 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.47e-04 | 428 | 82 | 8 | JC_hmvEC_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SNED1 SLIT2 BMP5 PATZ1 LAMB1 LHFPL2 NID1 DLK1 GDF10 LTBP4 SVEP1 | 2.50e-04 | 801 | 82 | 11 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 2.87e-04 | 814 | 82 | 11 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.90e-04 | 160 | 82 | 5 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500 | SLIT2 BMP5 BMP7 FRAS1 SPINT1 MICAL2 PATZ1 PLCH2 ELAPOR1 LAMA5 DLK1 DLL1 PRAG1 DNASE1 ITIH2 | 4.03e-04 | 1453 | 82 | 15 | facebase_RNAseq_e10.5_OlfacPit_2500 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.16e-04 | 250 | 82 | 6 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | SNED1 BMP1 BMP5 USP13 FAT4 FBN2 PTPRM PRICKLE1 GAS6 LAMA2 SRPX LTBP4 SVEP1 | 4.33e-04 | 1148 | 82 | 13 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.39e-04 | 354 | 82 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | NBPF3 HSPG2 BMP7 FBLN1 MGAT5 FBN2 PTPRM MATN3 LAMA1 LAMB1 LHFPL2 DLK1 PRAG1 | 4.52e-04 | 1153 | 82 | 13 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.88e-04 | 168 | 82 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.22e-04 | 261 | 82 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 5.53e-04 | 740 | 82 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#4_top-relative-expression-ranked_200 | 5.72e-04 | 42 | 82 | 3 | gudmap_developingKidney_e15.5_S-shaped body_200_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | 7.66e-04 | 772 | 82 | 10 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_100 | 7.92e-04 | 11 | 82 | 2 | gudmap_developingGonad_e18.5_epididymis_100_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_500 | 8.26e-04 | 394 | 82 | 7 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_500 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | ACSL4 BMP7 GAS6 LAMA1 CNTNAP3 LAMA5 LAMB1 NID1 DLK1 LTBP2 SRPX DLL1 | 8.34e-04 | 1075 | 82 | 12 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.71e-04 | 191 | 82 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.00e-04 | 49 | 82 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.04e-04 | 111 | 82 | 4 | gudmap_developingKidney_e11.5_ureteric bud_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 9.76e-04 | 797 | 82 | 10 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 9.84e-04 | 406 | 82 | 7 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 9.95e-04 | 799 | 82 | 10 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#3_top-relative-expression-ranked_200 | 1.12e-03 | 13 | 82 | 2 | gudmap_developingKidney_e11.5_ureteric bud_200_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.16e-03 | 418 | 82 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#2_top-relative-expression-ranked_100 | 1.19e-03 | 54 | 82 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.19e-03 | 54 | 82 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | ACSL4 SNED1 BMP5 BMP8B FRAS1 SPINT1 PLCH2 LAMA5 DLK1 DLL1 LTBP4 | 1.26e-03 | 973 | 82 | 11 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 1.29e-03 | 827 | 82 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#1_top-relative-expression-ranked_200 | 1.33e-03 | 56 | 82 | 3 | gudmap_developingGonad_e18.5_testes_200_k1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | SNED1 HECW1 MPP4 CNTNAP1 GAS6 LAMA3 LTBP2 SRPX GDF10 CD96 SVEP1 | 1.35e-03 | 981 | 82 | 11 | PCBC_ctl_BronchSmoothMuscl_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_1000 | SELP SNED1 CNTNAP3B HSPG2 FAT4 MPP4 ELAPOR1 CNTNAP3 NID1 LTBP2 SRPX | 1.35e-03 | 981 | 82 | 11 | PCBC_ctl_PulmonMicrovasc_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | 1.39e-03 | 431 | 82 | 7 | gudmap_developingKidney_e13.5_podocyte cells_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | 1.40e-03 | 836 | 82 | 10 | gudmap_developingKidney_e15.5_Podocyte cells_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 1.40e-03 | 986 | 82 | 11 | PCBC_EB_fibroblast_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.40e-03 | 125 | 82 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | 1.49e-03 | 994 | 82 | 11 | PCBC_ratio_EB_vs_SC_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#2_top-relative-expression-ranked_500 | 1.58e-03 | 129 | 82 | 4 | gudmap_developingGonad_e16.5_testes_500_k2 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 1.60e-03 | 219 | 82 | 5 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | 1.65e-03 | 855 | 82 | 10 | gudmap_developingKidney_e13.5_podocyte cells_1000 | |
| CoexpressionAtlas | EB bone marrow_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.69e-03 | 446 | 82 | 7 | PCBC_ratio_EB bone marrow_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#4_top-relative-expression-ranked_500 | 1.71e-03 | 16 | 82 | 2 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k4 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | SLIT2 BMP5 FBLN1 FAT4 FRAS1 LAMA2 LAMB1 NID1 LTBP2 GDF10 LTBP4 SVEP1 | 4.23e-15 | 200 | 85 | 12 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | SLIT2 BMP5 FBLN1 FAT4 FRAS1 LAMA2 LAMB1 NID1 LTBP2 GDF10 LTBP4 SVEP1 | 4.23e-15 | 200 | 85 | 12 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SLIT2 BMP5 FBLN1 FAT4 FRAS1 LAMA2 LAMB1 NID1 LTBP2 GDF10 LTBP4 SVEP1 | 4.23e-15 | 200 | 85 | 12 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | SNED1 SLIT2 FBLN1 LAMA2 LAMB1 NID1 DLK1 LTBP2 SRPX LTBP4 SVEP1 | 8.23e-14 | 188 | 85 | 11 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SLIT2 HSPG2 FBLN1 FBN2 LAMA2 LAMB1 NID1 SRPX GDF10 LTBP4 SVEP1 | 1.04e-13 | 192 | 85 | 11 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SLIT2 HSPG2 FBLN1 FBN2 LAMA2 LAMB1 NID1 SRPX GDF10 LTBP4 SVEP1 | 1.04e-13 | 192 | 85 | 11 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SLIT2 HSPG2 FBLN1 FBN2 LAMA2 LAMB1 NID1 SRPX GDF10 LTBP4 SVEP1 | 1.04e-13 | 192 | 85 | 11 | ac1477433704573f95111eee6263b93668d2845e |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SNED1 BMP1 HSPG2 FBLN1 GAS6 LAMA2 LAMB1 NID1 SRPX GDF10 LTBP4 | 1.30e-13 | 196 | 85 | 11 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SNED1 BMP1 HSPG2 FBLN1 GAS6 LAMA2 LAMB1 NID1 SRPX GDF10 LTBP4 | 1.30e-13 | 196 | 85 | 11 | 787c6cd92035e0b1108c2c086c42a229016e476b |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SLIT2 BMP5 FBLN1 FAT4 LAMA2 LAMB1 NID1 LTBP2 GDF10 LTBP4 SVEP1 | 1.38e-13 | 197 | 85 | 11 | 94a9603cbd3516fbcce871909693b88f20d41713 |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | SLIT2 BMP5 FBLN1 FAT4 LAMA2 LAMB1 NID1 LTBP2 GDF10 LTBP4 SVEP1 | 1.38e-13 | 197 | 85 | 11 | d51f484b4e01ac64233950d0b97fa88825ea1dbb |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | SLIT2 BMP5 FBLN1 MATN3 LAMB1 NID1 SRPX GDF10 LTBP4 ZYX SVEP1 | 1.63e-13 | 200 | 85 | 11 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SNED1 SLIT2 BMP5 FBLN1 LAMA2 LAMB1 NID1 SRPX GDF10 LTBP4 SVEP1 | 1.63e-13 | 200 | 85 | 11 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SNED1 SLIT2 BMP5 FBLN1 FAT4 LAMA2 LAMB1 NID1 LTBP2 SRPX SVEP1 | 1.63e-13 | 200 | 85 | 11 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SLIT2 BMP5 FBLN1 FAT4 LAMA2 LAMB1 NID1 LTBP2 SRPX GDF10 SVEP1 | 1.63e-13 | 200 | 85 | 11 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SNED1 SLIT2 BMP5 FBLN1 FAT4 LAMA2 LAMB1 NID1 LTBP2 SRPX SVEP1 | 1.63e-13 | 200 | 85 | 11 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | SLIT2 BMP5 FBLN1 MATN3 LAMB1 NID1 SRPX GDF10 LTBP4 ZYX SVEP1 | 1.63e-13 | 200 | 85 | 11 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SNED1 SLIT2 BMP5 FBLN1 LAMA2 LAMB1 NID1 SRPX GDF10 LTBP4 SVEP1 | 1.63e-13 | 200 | 85 | 11 | 1c10597edd532bf172ca09870a937d35e2585081 |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SNED1 SLIT2 BMP5 FBLN1 LAMA2 LAMB1 NID1 SRPX GDF10 LTBP4 SVEP1 | 1.63e-13 | 200 | 85 | 11 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | SNED1 SLIT2 FBLN1 PRICKLE1 LAMA2 LAMB1 NID1 LTBP2 SRPX SVEP1 | 2.59e-12 | 185 | 85 | 10 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.88e-12 | 187 | 85 | 10 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | SLIT2 BMP5 BMP7 FBLN1 FRAS1 PRICKLE1 LAMA2 LAMB1 LTBP2 SVEP1 | 3.56e-12 | 191 | 85 | 10 | e30ae7a12439f8a79820b13f03e822c1223fd0cb |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | SLIT2 BMP5 BMP7 FBLN1 FRAS1 PRICKLE1 LAMA2 LAMB1 LTBP2 SVEP1 | 3.56e-12 | 191 | 85 | 10 | 1726add3f392a061536b7aff72ba84303f4a0b1f |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.56e-12 | 191 | 85 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-12 | 192 | 85 | 10 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-12 | 192 | 85 | 10 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-12 | 193 | 85 | 10 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.95e-12 | 193 | 85 | 10 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 4.16e-12 | 194 | 85 | 10 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | SNED1 SLIT2 FBLN1 PRICKLE1 LAMA2 LAMB1 LHFPL2 LTBP2 LTBP4 SVEP1 | 4.16e-12 | 194 | 85 | 10 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 4.16e-12 | 194 | 85 | 10 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-12 | 195 | 85 | 10 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.38e-12 | 195 | 85 | 10 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-12 | 195 | 85 | 10 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.38e-12 | 195 | 85 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-12 | 195 | 85 | 10 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-12 | 195 | 85 | 10 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-12 | 195 | 85 | 10 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-12 | 195 | 85 | 10 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 4.60e-12 | 196 | 85 | 10 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-12 | 196 | 85 | 10 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-12 | 196 | 85 | 10 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.60e-12 | 196 | 85 | 10 | d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-12 | 196 | 85 | 10 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-12 | 196 | 85 | 10 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-12 | 196 | 85 | 10 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-12 | 196 | 85 | 10 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-12 | 197 | 85 | 10 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.09e-12 | 198 | 85 | 10 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.09e-12 | 198 | 85 | 10 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.09e-12 | 198 | 85 | 10 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.09e-12 | 198 | 85 | 10 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.35e-12 | 199 | 85 | 10 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.35e-12 | 199 | 85 | 10 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.35e-12 | 199 | 85 | 10 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.35e-12 | 199 | 85 | 10 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-12 | 199 | 85 | 10 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.35e-12 | 199 | 85 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.35e-12 | 199 | 85 | 10 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.63e-12 | 200 | 85 | 10 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.63e-12 | 200 | 85 | 10 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-12 | 200 | 85 | 10 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.63e-12 | 200 | 85 | 10 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-12 | 200 | 85 | 10 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.63e-12 | 200 | 85 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 5.63e-12 | 200 | 85 | 10 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SLIT2 FBLN1 FAT4 HECW1 PRICKLE1 LAMA2 LAMB1 NID1 LTBP2 SVEP1 | 5.63e-12 | 200 | 85 | 10 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-11 | 171 | 85 | 9 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-11 | 171 | 85 | 9 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.12e-11 | 186 | 85 | 9 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.12e-11 | 186 | 85 | 9 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 9.57e-11 | 187 | 85 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-11 | 187 | 85 | 9 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-11 | 187 | 85 | 9 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-11 | 187 | 85 | 9 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-10 | 191 | 85 | 9 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.16e-10 | 191 | 85 | 9 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-10 | 191 | 85 | 9 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-10 | 192 | 85 | 9 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-10 | 192 | 85 | 9 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.21e-10 | 192 | 85 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-10 | 192 | 85 | 9 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-10 | 192 | 85 | 9 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-10 | 192 | 85 | 9 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.21e-10 | 192 | 85 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-10 | 193 | 85 | 9 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.27e-10 | 193 | 85 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.27e-10 | 193 | 85 | 9 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-10 | 193 | 85 | 9 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-10 | 194 | 85 | 9 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-10 | 194 | 85 | 9 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 1.39e-10 | 195 | 85 | 9 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.39e-10 | 195 | 85 | 9 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-10 | 195 | 85 | 9 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.39e-10 | 195 | 85 | 9 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-10 | 195 | 85 | 9 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-10 | 196 | 85 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.52e-10 | 197 | 85 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-10 | 197 | 85 | 9 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.52e-10 | 197 | 85 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| Computational | Adhesion molecules. | SELP FBN2 CNTNAP1 LAMA2 LAMA3 LAMA5 LAMB1 NID1 SRPX ITGAM ZYX | 1.47e-10 | 141 | 57 | 11 | MODULE_122 |
| Computational | Metal / Ca ion binding. | 5.99e-06 | 133 | 57 | 7 | MODULE_324 | |
| Computational | Ovary genes. | 1.23e-04 | 368 | 57 | 9 | MODULE_1 | |
| Computational | Placenta genes. | 1.39e-04 | 463 | 57 | 10 | MODULE_38 | |
| Computational | Fetal liver genes - metabolism and xenobiotics. | 5.75e-04 | 453 | 57 | 9 | MODULE_24 | |
| Drug | AC1L1G72 | 2.75e-10 | 11 | 84 | 5 | CID000003553 | |
| Drug | kalinin | 1.27e-09 | 55 | 84 | 7 | CID000032518 | |
| Drug | Calcort | 5.28e-09 | 38 | 84 | 6 | CID000026709 | |
| Drug | AC1L9Q5W | 5.49e-09 | 106 | 84 | 8 | CID000452221 | |
| Drug | AC1L1B58 | 6.71e-08 | 29 | 84 | 5 | CID000001288 | |
| Drug | I-Q-S | 1.14e-07 | 156 | 84 | 8 | CID000003540 | |
| Drug | Rgds Peptide | 1.31e-07 | 106 | 84 | 7 | CID000107775 | |
| Drug | Rgd Peptide | 2.47e-07 | 239 | 84 | 9 | CID000104802 | |
| Drug | Ikvav | 2.76e-07 | 38 | 84 | 5 | CID000131343 | |
| Drug | dysprosium | 3.19e-07 | 74 | 84 | 6 | CID000023912 | |
| Drug | YIGSR | 4.72e-07 | 79 | 84 | 6 | CID000123977 | |
| Drug | Grgds | 6.33e-07 | 83 | 84 | 6 | CID000123811 | |
| Drug | NSC 714187 | 7.29e-07 | 85 | 84 | 6 | CID005288693 | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; MCF7; HT_HG-U133A | 7.31e-07 | 199 | 84 | 8 | 5523_UP | |
| Drug | alpha-D-glucose 1-phosphate 6-vanadate | 8.95e-07 | 88 | 84 | 6 | CID005289552 | |
| Drug | LMWH | SELP PHKA2 SLIT2 HSPG2 FBLN1 LAMA1 LAMA2 LAMA3 LAMA5 LAMB1 CPB2 FGG ITGAM | 9.02e-07 | 663 | 84 | 13 | CID000000772 |
| Drug | ALT-711 | 9.83e-07 | 21 | 84 | 4 | CID000216304 | |
| Drug | H-9 dihydrochloride | 1.02e-06 | 90 | 84 | 6 | CID000003544 | |
| Drug | Sikvav | 1.73e-06 | 24 | 84 | 4 | CID005487517 | |
| Drug | CC270 | 2.59e-06 | 59 | 84 | 5 | CID006918852 | |
| Drug | AC1L9INI | 2.59e-06 | 59 | 84 | 5 | CID000445839 | |
| Drug | LG 5 | 2.82e-06 | 60 | 84 | 5 | CID011840957 | |
| Drug | Cerebro | 3.30e-06 | 28 | 84 | 4 | CID000005354 | |
| Drug | AC1L1C2F | 3.32e-06 | 110 | 84 | 6 | CID000001711 | |
| Drug | BM165 | 7.82e-06 | 11 | 84 | 3 | CID003352881 | |
| Drug | Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 8.14e-06 | 196 | 84 | 7 | 3971_UP | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 8.42e-06 | 197 | 84 | 7 | 2786_UP | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 8.42e-06 | 197 | 84 | 7 | 4382_DN | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 8.42e-06 | 197 | 84 | 7 | 4123_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; MCF7; HT_HG-U133A | 8.70e-06 | 198 | 84 | 7 | 4346_UP | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 8.99e-06 | 199 | 84 | 7 | 4400_UP | |
| Drug | 2-amino-5-methylpyridine | 9.72e-06 | 77 | 84 | 5 | CID000015348 | |
| Drug | ICI 192605 | 1.35e-05 | 2 | 84 | 2 | ctd:C057498 | |
| Drug | hexametazine | 1.35e-05 | 2 | 84 | 2 | CID009552070 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.40e-05 | 83 | 84 | 5 | CID011968896 | |
| Drug | maltos | 1.46e-05 | 393 | 84 | 9 | CID000000294 | |
| Drug | Levonorgestrel | 1.49e-05 | 215 | 84 | 7 | ctd:D016912 | |
| Drug | 1,2-dimethylhydrazine | 1.67e-05 | 86 | 84 | 5 | CID000001322 | |
| Drug | poly-N-acetyllactosamine | 1.87e-05 | 88 | 84 | 5 | CID000119547 | |
| Drug | calcium phosphate | 1.90e-05 | 149 | 84 | 6 | CID000024441 | |
| Drug | Mk 0852 | 2.62e-05 | 16 | 84 | 3 | CID000164406 | |
| Drug | hydroxyapatite | 4.12e-05 | 171 | 84 | 6 | CID000014781 | |
| Drug | 2,4-diaminopyrimidine | 4.74e-05 | 54 | 84 | 4 | CID000067431 | |
| Drug | Gdrgdsp | 5.24e-05 | 109 | 84 | 5 | CID000115346 | |
| Drug | Ursolic acid [77-52-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 5.83e-05 | 182 | 84 | 6 | 2230_UP | |
| Drug | icariin | 5.87e-05 | 57 | 84 | 4 | CID005318997 | |
| Drug | N-acetylhexosamine | 6.09e-05 | 472 | 84 | 9 | CID000000899 | |
| Drug | B-Ms | 6.49e-05 | 114 | 84 | 5 | CID000445091 | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 6.57e-05 | 186 | 84 | 6 | 6793_UP | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 7.18e-05 | 189 | 84 | 6 | 5675_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 8.06e-05 | 193 | 84 | 6 | 3627_DN | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; HL60; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 2569_UP | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 3371_UP | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 4366_DN | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 4407_UP | |
| Drug | Chlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 4142_DN | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; PC3; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 3719_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 2269_DN | |
| Drug | Trimethadione [127-48-0]; Up 200; 28uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 4165_UP | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; HL60; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 3076_UP | |
| Drug | Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 7199_UP | |
| Drug | Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 4164_DN | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 4650_UP | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 5278_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 5867_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 2849_UP | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 4133_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 3728_UP | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; HL60; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 3113_UP | |
| Drug | Streptozotocin [18883-66-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 6098_UP | |
| Drug | Phenacetin [62-44-2]; Up 200; 22.4uM; HL60; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 2471_UP | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 6086_DN | |
| Drug | C75; Up 200; 10uM; MCF7; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 6394_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 9.81e-05 | 200 | 84 | 6 | 3896_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.81e-05 | 200 | 84 | 6 | 4379_DN | |
| Drug | G 3012 | 1.30e-04 | 132 | 84 | 5 | CID000120739 | |
| Drug | c7E3 | 1.33e-04 | 27 | 84 | 3 | CID003413300 | |
| Drug | Foropafant | 1.34e-04 | 5 | 84 | 2 | ctd:C071317 | |
| Drug | chondroitin sulfate | 1.43e-04 | 413 | 84 | 8 | CID000024766 | |
| Drug | trypanothione disulfide | 1.71e-04 | 140 | 84 | 5 | CID000115098 | |
| Drug | inogatran | 1.83e-04 | 30 | 84 | 3 | CID000066005 | |
| Drug | t180 | 2.00e-04 | 6 | 84 | 2 | CID002782538 | |
| Drug | Ro 44-9883 | 2.02e-04 | 31 | 84 | 3 | CID000071453 | |
| Drug | sodium pentaborate | 2.44e-04 | 33 | 84 | 3 | ctd:C538809 | |
| Drug | rhamnose | 3.48e-04 | 356 | 84 | 7 | CID000000840 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 8.30e-07 | 26 | 83 | 4 | DOID:9351 (implicated_via_orthology) | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.19e-06 | 8 | 83 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 3.30e-05 | 215 | 83 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | dextro-looped transposition of the great arteries (implicated_via_orthology) | 4.67e-05 | 4 | 83 | 2 | DOID:0060770 (implicated_via_orthology) | |
| Disease | stroke, response to clopidogrel, cardiovascular event measurement | 1.63e-04 | 7 | 83 | 2 | EFO_0000712, EFO_0006919, GO_1903493 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 3.47e-04 | 10 | 83 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Marfan syndrome (implicated_via_orthology) | 3.47e-04 | 10 | 83 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | Mitral valve prolapse, response to surgery | 5.07e-04 | 12 | 83 | 2 | EFO_0009951, HP_0001634 | |
| Disease | intermediate coronary syndrome (is_marker_for) | 5.98e-04 | 13 | 83 | 2 | DOID:8805 (is_marker_for) | |
| Disease | hyperglycemia (is_marker_for) | 5.98e-04 | 13 | 83 | 2 | DOID:4195 (is_marker_for) | |
| Disease | FEV/FEC ratio | HSPG2 FBLN1 FRAS1 MGAT5 FCGBP PTPRM CRLF3 LHFPL2 LTBP2 BMP8A LTBP4 | 6.43e-04 | 1228 | 83 | 11 | EFO_0004713 |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 6.96e-04 | 14 | 83 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | biliary atresia (is_marker_for) | 6.96e-04 | 14 | 83 | 2 | DOID:13608 (is_marker_for) | |
| Disease | osteoarthritis (implicated_via_orthology) | 8.02e-04 | 15 | 83 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | common carotid intimal medial thickness | 9.03e-04 | 67 | 83 | 3 | EFO_0004860 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.07e-04 | 152 | 83 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.30e-03 | 19 | 83 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 1.44e-03 | 20 | 83 | 2 | C0026760 | |
| Disease | Hodgkins lymphoma | 1.62e-03 | 82 | 83 | 3 | EFO_0000183 | |
| Disease | partial thromboplastin time | 2.07e-03 | 24 | 83 | 2 | EFO_0004310 | |
| Disease | response to gemcitabine | 2.25e-03 | 25 | 83 | 2 | GO_0036272 | |
| Disease | blood chromium measurement | 2.43e-03 | 26 | 83 | 2 | EFO_0007579 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NYCSFEDSDCGFSPG | 811 | Q6UXC1 | |
| ISCFTYGCRIGYSSP | 331 | O60488 | |
| GYFGFVCVERSSPCY | 381 | Q5RHP9 | |
| GVTCDCAFSAYDGPF | 981 | Q9BZ76 | |
| YTCDCDLTAFDGPYC | 981 | P78357 | |
| GVDSYYCHCPFGVFG | 3956 | Q6V0I7 | |
| LDDGLYECSCAPGYS | 106 | P80370 | |
| TLGSYKCSCDPGYEL | 566 | P13497 | |
| PEGYAAYYCEGECAF | 351 | P18075 | |
| CYYVFGDLSGGCESY | 501 | O14641 | |
| GYRGPSCQDCDTGYT | 1131 | P98160 | |
| AAGEFCELCAPGYYG | 1586 | P98160 | |
| CELCAPGYYGDATAG | 1591 | P98160 | |
| GYYESGDFCIPLCTE | 91 | A6BM72 | |
| GCQFSPSEYFYDGSC | 6 | P13349 | |
| SECPGGYYADATGRC | 591 | Q86XX4 | |
| VSDGAASYHCDCYPG | 406 | O15232 | |
| SCGESSYDDYFSPDN | 406 | Q8NEM0 | |
| AGDSCQGCSPGYYRD | 1661 | Q16787 | |
| QDPSCCSGALYYGSK | 646 | P19823 | |
| PCYADYGVDGSTCSF | 171 | Q09328 | |
| GSSYLEGCLACATAY | 71 | Q2TAP0 | |
| SCYSASCYSPSCYNG | 696 | Q76N89 | |
| SCYSPSCYNGNRFAS | 701 | Q76N89 | |
| SDVGSSCTSCPAGYY | 596 | Q6UXG2 | |
| SCTSCPAGYYIDRDS | 601 | Q6UXG2 | |
| SPKSFDAYYCAGACE | 396 | P55107 | |
| SDPCYAFFGVDGTEC | 181 | Q3V5L5 | |
| YATGFCCSCVAGYTG | 406 | P14543 | |
| QSCGSLYFGCSFFYP | 421 | Q8IUI8 | |
| CTGSCYSAVGAPYEE | 401 | Q96JB8 | |
| PIVYCSDGFCELTGY | 41 | Q9UQ05 | |
| YCGHYASAYKPGDCS | 166 | Q6ZUX7 | |
| FSYGCAEGSCYPATG | 26 | P07942 | |
| PGTTGRYCELCADGY | 891 | P24043 | |
| YSGLSCEACLPGFYR | 1386 | P24043 | |
| SYRGDSCQECAPGFY | 1836 | O15230 | |
| GAACSPGYSCTAAYP | 261 | P52952 | |
| DASCGPSGCYTYQVS | 6 | Q9HBE1 | |
| GCFESLYAEYCETCG | 241 | Q96MT3 | |
| SPGSFRCECKTGYYF | 376 | P23142 | |
| DSCQPYGSCFYSLEE | 511 | Q9H094 | |
| FFSGCSRYTNCDTGY | 141 | Q86YG4 | |
| FGSYCPTTCGIADFL | 41 | P02679 | |
| SSSCSETYCGLYPES | 271 | Q96IY4 | |
| SYTCSCRPGYTGATC | 311 | O00548 | |
| HYEACSYGCPLSCGD | 1141 | Q9Y6R7 | |
| SYYYDDGCEPCGNDT | 116 | P24855 | |
| PGSYSCLCDEGFAYS | 216 | Q14393 | |
| APQGYSAYYCEGECS | 321 | Q7Z5Y6 | |
| SAYYCEGECSFPLDS | 326 | Q7Z5Y6 | |
| GYAAFYCDGECSFPL | 376 | P22003 | |
| ADFCAGPAYSSYSTL | 16 | O60759 | |
| CFCYPGYTLATSGAT | 911 | Q14767 | |
| ETIGNYTCSCYPGFY | 176 | P16109 | |
| VNTAPGYSCYCSNGY | 1271 | Q8N2S1 | |
| YFCVCPRGYVTSTDG | 341 | P35556 | |
| TVGSYNCLCYPGFEL | 1951 | P35556 | |
| TFGSYECTCPIGYAL | 2271 | P35556 | |
| APQGYSAYYCEGECS | 321 | P34820 | |
| SAYYCEGECSFPLDS | 326 | P34820 | |
| TDYCPDCGNRSFYDL | 361 | H0Y7S4 | |
| GVTCDCAFSAYDGPF | 981 | Q96NU0 | |
| ICHFFYDSAPSGAYG | 1196 | P46019 | |
| SFPLNLGGSDTCYFC | 991 | O94851 | |
| GCLFDEPYSTCGYSQ | 26 | P28827 | |
| GFYAYQDGSCTPCDC | 986 | P25391 | |
| RPDTGDDAASYGFCY | 31 | Q8NEA9 | |
| DDAASYGFCYCPGSH | 36 | Q8NEA9 | |
| GTDYCPDCGNRSFYD | 456 | A6NGN4 | |
| GGYCSPAEGFSSRYE | 1016 | Q9C0A6 | |
| DIEYFSPCFAGCTYS | 521 | Q86UG4 | |
| GSLYQCDYSTGSCEP | 61 | P11215 | |
| GAYFNSRCEYYCSPG | 136 | P78539 | |
| YSYSGLETCESCPLG | 1061 | Q4LDE5 | |
| SGGGAYLCVCPESFF | 846 | Q8TER0 | |
| SNCCFDPLLYFFSGG | 286 | Q9Y271 | |
| PFRCSSCGEGFANTY | 1016 | P0CJ78 | |
| PYYCTEPGCGRAFAS | 356 | P52747 | |
| GDRPYYCTECGNSFT | 241 | P17023 | |
| GFYCAYGRPCESLVT | 76 | P40200 | |
| YPDGSFDPNCCFSIY | 111 | O75038 | |
| PFSEHCARFTYGGCY | 411 | O43278 | |
| KFYTCGYCTEDSPSF | 1041 | Q92610 | |
| CHSFFKYSYCTGEAG | 446 | O95391 | |
| DGDGTCECYSAYTGP | 176 | Q8WWQ8 | |
| LGQPYCECSSGYTGD | 1431 | O94813 | |
| HSGTFPFTCQYCSYG | 256 | Q6AHZ1 | |
| AIYYCATCSEDPGST | 1006 | Q86YV5 | |
| ENCGSYCYSSSGPCQ | 236 | O95789 | |
| SLEGAPYCEGCYTDT | 426 | Q15942 | |
| PYECSECGKFFPYSS | 356 | Q13106 | |
| GYSFNPVCASDGSSY | 196 | Q8IYR6 | |
| FSYDSPNSEGGLYVC | 51 | Q92995 | |
| AGFFCPICSLFYSGE | 1926 | Q14966 |